GLP-1 Market
LLY $1351.12 ▼ -2.3% NVO $38.87 ▼ -1.4% PFE $27.54 ▼ -1.9% VKTX $25.84 ▼ -1.3% KLRA $11.58 ▼ -1.8% GPCR $17.12 ▼ -1.4% RHHBY $58.99 ▼ -0.9%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

COVID-19 vaccine

COVID-19 vaccine

Company
Swiss Federal Institute of Technology
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
24 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

24 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 20, 2026

Find a Clinical Trial Near Me

See recruiting studies for COVID-19 vaccine and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03501576

    Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma

    Emory University 200 participants Est. completion 2028-05-26 2 sites
    Other conditions: Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT04706390

    Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination

    University of Bergen 2500 participants Est. completion 2030-12-12 1 site
    Other conditions: Covid19
    View official trial listing →
  • Recruiting NCT NCT05046002

    COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry

    Ottawa Heart Institute Research Corporation 400 participants Est. completion 2026-12-31 1 site
    Other conditions: Myocarditis, Pericarditis
    View official trial listing →
  • Recruiting NCT NCT05197621

    The Impact of COVID-19 on Maternal and Neonatal Outcomes

    Johns Hopkins University 300 participants Est. completion 2028-05-05 1 site
    Other conditions: COVID-19, Pregnancy; Infection
    View official trial listing →
  • Recruiting NCT NCT05415267

    Immunosuppression and COVID-19 Boosters

    Not yet reported Kirby Institute 320 participants Est. completion 2026-12-31 5 sites
    Other conditions: COVID-19
    View official trial listing →
  • Recruiting NCT NCT05571735

    Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

    University of Oxford 133 participants Est. completion 2026-06-30 1 site
    Other conditions: Covid-19 Pandemics, Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT05691790

    Older People's Preventive Care Utilization

    Not yet reported The University of Hong Kong 270 participants Est. completion 2025-05-31 1 site
    Other conditions: Health Communication
    View official trial listing →
  • Recruiting NCT NCT05973084

    COVID-19 Transmission and Morbidity in Malawi

    Boston University 1500 participants Est. completion 2028-03 2 sites
    Other conditions: SARS CoV 2 Infection, SARS CoV 2 Vaccination
    View official trial listing →
  • Recruiting NCT NCT06103123

    MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study

    Cardiology Research UBC 500 participants Est. completion 2027-04-23 1 site
    Other conditions: Myocarditis, Myocarditis Acute, Pericarditis, Pericarditis Acute
    View official trial listing →
  • Recruiting NCT NCT06168032

    COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research

    Not yet reported Peking Union Medical College Hospital 1224 participants Est. completion 2026-12-08 1 site
    Other conditions: COVID-19 Recurrent, Lung Cancer, Vaccination, Antibody, Chemotherapy, Immune Checkpoint Inhibitor
    View official trial listing →
  • Recruiting NCT NCT06355232

    Covid-19 and Influenza Oral Vaccine Study

    Not yet reported Vaxine Pty Ltd 100 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: covid19 Infection, Influenza, Human
    View official trial listing →
  • Recruiting NCT NCT06381739

    A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol

    Not yet reported McMaster University 350 participants Est. completion 2027-01 2 sites
    Other conditions: COVID-19 Infection
    View official trial listing →
  • Recruiting NCT NCT06441955

    Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.

    Not yet reported Well- Konnect Healthcare Services and Research Firm 100 participants Est. completion 2030-09-30 1 site
    Other conditions: COVID-19, Long Haul
    View official trial listing →
  • Recruiting NCT NCT06452654

    Anti-viral Action Against Type 1 Diabetes Autoimmunity

    Not yet reported Technical University of Munich 2252 participants Est. completion 2027-10 9 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Recruiting NCT NCT06635525

    Impact Of Kidney Failure On The Regulation Of Humoral Response To Vaccination

    Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 146 participants Est. completion 2026-07 3 sites
    Chronic kidney disease Other conditions: Vaccine Response
    View official trial listing →
  • Recruiting NCT NCT06821126

    Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults

    Not yet reported, Not yet reported ANRS, Emerging Infectious Diseases 238 participants Est. completion 2028-03 5 sites
    Other conditions: Healthy
    View official trial listing →
  • Recruiting NCT NCT06848309

    Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2

    Washington University School of Medicine 300 participants Est. completion 2029-10 1 site
    Other conditions: Influenza, SARS-CoV-2 (COVID-19) Infection, Immune Response of Host
    View official trial listing →
  • Recruiting NCT NCT07287137

    Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study

    Not yet reported Henry M. Jackson Foundation for the Advancement of Military Medicine 54 participants Est. completion 2027-09 1 site
    Other conditions: COVID -19, COVID - 19, COVID 19, Influenza, Respiratory Virus, Respiratory Viruses, Respiratory Virus Infection, Respiratory Virus Infections
    View official trial listing →
  • Recruiting NCT NCT07464314

    A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

    Not yet reported GlaxoSmithKline 225 participants Est. completion 2027-06-03 12 sites
    Other conditions: Influenza, Human+COVID-19
    View official trial listing →
  • Recruiting NCT NCT07597070

    Universal Immunization to Fortify Immunotherapy Efficacy and Response

    Not yet reported University of Florida 500 participants Est. completion 2035-03 1 site
    Other conditions: Stage 4 NSCLC
    View official trial listing →
  • Recruiting NCT NCT07605520

    An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of Experimental Versus Authorized SARS-CoV-2 Vaccine Candidates as a Booster Dose in Healthy Participants Previously Vaccinated With Authorized mRNA SARS-CoV-2 Vaccines.

    Not yet reported ANRS, Emerging Infectious Diseases 48 participants Est. completion 2028-12 3 sites
    Other conditions: Healthy Adults
    View official trial listing →
  • Recruiting NCT NCT07658196

    TLR9 Immunotherapy for Peritoneal Carcinomatosis

    Not yet reported Brown University 24 participants Est. completion 2030-07 1 site
    Other conditions: Malignant Ascites, Colorectal Adenocarcinoma, Peritoneal (Metastatic) Cancer, Appendiceal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07730450

    A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age

    Not yet reported BioNTech SE 200 participants Est. completion 2027-08-20 5 sites
    Other conditions: COVID-19 Vaccines
    View official trial listing →
  • Recruiting NCT NCT07863635

    A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations

    Not yet reported ModernaTX, Inc. 600 participants Est. completion 2026-12-11 5 sites
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Completed NCT NCT03092076

    The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy Chinese

    Not yet reported Guangdong Provincial People's Hospital 51 participants Est. completion 2016-06-16
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT03305341

    Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix

    Not yet reported Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair 20 participants Est. completion 2026-12-28 1 site Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04341389

    A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector)

    Not yet reported Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China 508 participants Est. completion 2020-12-31 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04368728

    Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals

    Not yet reported, Not yet reported BioNTech SE 46969 participants Est. completion 2023-02-10 175 sites
    Other conditions: SARS-CoV-2 Infection, COVID-19
    View official trial listing →
  • Completed NCT NCT04380701

    A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults

    Not yet reported, Not yet reported BioNTech SE 512 participants Est. completion 2022-04-13 5 sites
    Other conditions: Infections, Respiratory, Virus Diseases, Infection Viral, Vaccine Adverse Reaction, RNA Virus Infections, Protection Against COVID-19 and Infections With SARS CoV 2
    View official trial listing →
  • Completed NCT NCT04400838

    Investigating a Vaccine Against COVID-19

    Not yet reported, Not yet reported University of Oxford 10811 participants Est. completion 2025-02-05 20 sites
    Other conditions: Coronavirus
    View official trial listing →
  • Completed NCT NCT04405908

    SCB-2019 as COVID-19 Vaccine

    Not yet reported Clover Biopharmaceuticals AUS Pty 166 participants Est. completion 2021-12-08 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04436276

    A Study of Ad26.COV2.S in Adults (COVID-19)

    Not yet reported, Not yet reported Janssen Vaccines & Prevention B.V. 1085 participants Est. completion 2023-02-21 12 sites
    Other conditions: Covid-19 Prevention
    View official trial listing →
  • Status unknown NCT NCT04444674

    COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection

    Not yet reported, Not yet reported University of Oxford 2130 participants Est. completion 2021-12 7 sites
    Other conditions: Coronavirus
    View official trial listing →
  • Completed NCT NCT04449276

    A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

    Not yet reported CureVac 280 participants Est. completion 2021-12-21 4 sites
    Other conditions: Severe Acute Respiratory Syndrome, Coronavirus, SARS-CoV-2, COVID-19
    View official trial listing →
  • Completed NCT NCT04460703

    COVID-19 Vaccine Messaging, Part 1

    Not yet reported Yale University 4000 participants Est. completion 2020-07-08 1 site
    Other conditions: Vaccination, COVID-19
    View official trial listing →
  • Completed NCT NCT04470609

    Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years

    Not yet reported, Not yet reported Institute of Medical Biology, Chinese Academy of Medical Sciences 471 participants Est. completion 2021-10-27 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04495933

    A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults

    Not yet reported The University of Queensland 216 participants Est. completion 2024-04-30 1 site
    Other conditions: SARS-CoV2, Covid19
    View official trial listing →
  • Completed NCT NCT04497298

    Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine

    Not yet reported Institut Pasteur 90 participants Est. completion 2021-05-12 2 sites Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04505722

    A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants

    Not yet reported Janssen Vaccines & Prevention B.V. 44325 participants Est. completion 2023-03-31 225 sites
    Other conditions: Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol
    View official trial listing →
  • Completed NCT NCT04508075

    Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine

    Not yet reported PT Bio Farma 1620 participants Est. completion 2021-08-31 1 site
    Other conditions: SARS-CoV2 Infection
    View official trial listing →
  • Completed NCT NCT04530357

    Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine

    Not yet reported, Not yet reported Research Institute for Biological Safety Problems 244 participants Est. completion 2021-04-25 1 site
    Other conditions: Covid19, SARS-CoV Infection, Vaccine Adverse Reaction
    View official trial listing →
  • Completed NCT NCT04533399

    A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults

    Not yet reported Novavax 4422 participants Est. completion 2022-01-19 14 sites
    Other conditions: SARS-CoV-2 Infection, COVID-19
    View official trial listing →
  • Status unknown NCT NCT04536051

    A Study of a Candidate COVID-19 Vaccine (COV003)

    Not yet reported University of Oxford 10300 participants Est. completion 2021-09 6 sites
    Other conditions: Coronavirus
    View official trial listing →
  • Completed NCT NCT04537208

    Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older

    Not yet reported, Not yet reported Sanofi Pasteur, a Sanofi Company 441 participants Est. completion 2021-11-19 11 sites
    Other conditions: COVID-19 (Healthy Volunteers)
    View official trial listing →
  • Completed NCT NCT04551547

    Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19

    Not yet reported, Not yet reported Sinovac Research and Development Co., Ltd. 552 participants Est. completion 2023-02-08 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04560881

    Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)

    Not yet reported Laboratorio Elea Phoenix S.A. 3000 participants Est. completion 2021-12-13 4 sites
    Other conditions: COVID-19 Virus Infection
    View official trial listing →
  • Completed NCT NCT04582344

    Clinical Trial For SARS-CoV-2 Vaccine (COVID-19)

    Not yet reported Health Institutes of Turkey 10214 participants Est. completion 2022-07-27 25 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04583995

    A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom

    Not yet reported Novavax 15185 participants Est. completion 2022-03-29 33 sites
    Other conditions: SARS-CoV-2 Infection, COVID-19
    View official trial listing →
  • Status unknown NCT NCT04611243

    Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19

    Chinese University of Hong Kong 700 participants Est. completion 2026-02-17 1 site
    Other conditions: Lung Function, Exercise Capacity, Quality of Life, Covid19
    View official trial listing →
  • Status unknown NCT NCT04636333

    Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)

    Not yet reported Jiangsu Province Centers for Disease Control and Prevention 216 participants Est. completion 2022-07-07 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Active, not recruiting NCT NCT04636697

    Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

    Not yet reported, Not yet reported Medicago 30918 participants Est. completion 2022-04-30 91 sites
    Other conditions: SARS-CoV-2 Infection
    View official trial listing →
  • Completed NCT NCT04651790

    Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults

    Not yet reported Pontificia Universidad Catolica de Chile 2300 participants Est. completion 2022-11-01 1 site
    Other conditions: Covid19, Vaccines
    View official trial listing →
  • Status unknown NCT NCT04659239

    The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

    Not yet reported Chinese Academy of Medical Sciences 34020 participants Est. completion 2022-07 2 sites
    Other conditions: COVID-19
    View official trial listing →
  • Withdrawn NCT NCT04665258

    Male Reproduction COVID Sequelae Study (MARCOS).

    University of Miami Est. completion 2023-11-28
    Other conditions: Infertility, Male
    View official trial listing →
  • Completed NCT NCT04684446

    Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19

    Not yet reported, Not yet reported R-Pharm 100 participants Est. completion 2022-03-29 4 sites
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT04686409

    App-based Symptom Tracking After Corona Vaccination (CoCoV)

    University of Ulm 500 participants Est. completion 2022-08-31 1 site
    Other conditions: Adverse Events in COVID-19 Vaccination
    View official trial listing →
  • Completed NCT NCT04690387

    Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection

    Not yet reported Aivita Biomedical, Inc. 27 participants Est. completion 2021-01-15 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04691908

    Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine

    Not yet reported Research Institute for Biological Safety Problems 3000 participants Est. completion 2021-07-11 1 site
    Other conditions: Covid19, SARS-CoV Infection, Vaccine Adverse Reaction
    View official trial listing →
  • Completed NCT NCT04691947

    Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC

    Not yet reported Health Institutes of Turkey 44 participants Est. completion 2021-11-18 1 site
    Other conditions: COVID-19 Vaccine
    View official trial listing →
  • Status unknown NCT NCT04694651

    Potential Acceptance of COVID-19 Vaccines in Healthcare Workers in Egypt

    Assiut University 400 participants Est. completion 2021-02-15 2 sites
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04694664

    COVID-19 Vaccine Confidence Among Pregnant Women and Mothers

    Pregistry 18000 participants Est. completion 2020-12-01 1 site
    Other conditions: Pregnancy Related, Mothers
    View official trial listing →
  • Completed NCT NCT04695652

    A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult

    Not yet reported Medigen Vaccine Biologics Corp. 3854 participants Est. completion 2021-10-29 12 sites
    Other conditions: Covid19 Vaccine
    View official trial listing →
  • Completed NCT NCT04705116

    COVID-19 Vaccines International Pregnancy Exposure Registry

    Pregistry 1184 participants Est. completion 2026-04-26 1 site
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04706156

    Oral Side Effects of COVID-19 Vaccine

    Masaryk University 1540 participants Est. completion 2021-03-31 4 sites
    Other conditions: Oral Manifestations, Covid19, Vaccine Adverse Reaction
    View official trial listing →
  • Completed NCT NCT04706403

    Views on COVID-19 and Vaccination

    Not yet reported University of Massachusetts, Worcester 756 participants Est. completion 2021-02-01 1 site Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04713163

    COVID-19 Vaccine Induced Immunity

    University of Manitoba 200 participants Est. completion 2021-12
    Other conditions: Covid19
    View official trial listing →
  • Withdrawn NCT NCT04718467

    Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)

    Not yet reported Jiangsu Province Centers for Disease Control and Prevention Est. completion 2022-03-15 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04731870

    Exploring Vaccine Confidence and Uptake of Potential COVID-19 Vaccines

    East Carolina University 632 participants Est. completion 2023-03-31 1 site
    Other conditions: Coronavirus
    View official trial listing →
  • Status unknown NCT NCT04736524

    Immune Response Following COVID-19 Vaccination

    Texas Cardiac Arrhythmia Research Foundation 500 participants Est. completion 2022-03 1 site
    Other conditions: IgM and IgG in Blood
    View official trial listing →
  • Completed NCT NCT04748172

    COVID-19 Vaccine and Ovarian Reserve

    Sheba Medical Center 200 participants Est. completion 2023-06-01 1 site
    Other conditions: Fertility Issues, Vaccine Adverse Reaction
    View official trial listing →
  • Status unknown NCT NCT04748471

    Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y)

    Not yet reported Assistance Publique - Hôpitaux de Paris 180 participants Est. completion 2023-01-25
    Other conditions: Prevention of COVID19
    View official trial listing →
  • Completed NCT NCT04751734

    Impact of Maternal COVID-19 Vaccines on Breast Milk

    Institute of Agrochemistry and Food Technology, National Research Council 120 participants Est. completion 2023-12-31 2 sites
    Other conditions: COVID-19 Vaccines
    View official trial listing →
  • Completed NCT NCT04754594

    To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older

    Not yet reported, Not yet reported BioNTech SE 726 participants Est. completion 2022-07-15 90 sites
    Other conditions: SARS-CoV-2 Infection, COVID-19, Maternal Immunization
    View official trial listing →
  • Completed NCT NCT04754698

    COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS

    Not yet reported University of Sao Paulo General Hospital 2196 participants Est. completion 2024-03-22 1 site
    Other conditions: Rheumatic Disease, HIV Infections, AIDS, Safety Issues, Immunogenicity, COVID-19
    View official trial listing →
  • Status unknown NCT NCT04756323

    A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)

    Not yet reported Beijing Minhai Biotechnology Co., Ltd 1000 participants Est. completion 2022-02-28 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04760704

    Covid-19 Vaccine Response in Elderly Subjects

    University Hospital, Lille 264 participants Est. completion 2023-03-28 1 site
    Other conditions: Covid19 Vaccine
    View official trial listing →
  • Completed NCT NCT04760730

    Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)

    Not yet reported, Not yet reported R-Pharm 100 participants Est. completion 2022-07-26 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Withdrawn NCT NCT04761692

    Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake

    Not yet reported Charles Drew University of Medicine and Science Est. completion 2026-12-31 1 site
    Other conditions: Covid19, Influenza, Pneumonia, Vaccine Refusal
    View official trial listing →
  • Completed NCT NCT04761822

    COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 746 participants Est. completion 2022-04-27 29 sites Stand-alone
    Other conditions: SARS-CoV Infection, COVID-19, Allergic Reaction, Mast Cell Disorder
    View official trial listing →
  • Completed NCT NCT04764422

    Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand

    Not yet reported, Not yet reported Mahidol University 455 participants Est. completion 2022-09-12 1 site
    Other conditions: Covid-19, SARS Pneumonia, Pneumonia, Viral, Covid-19 Vaccine
    View official trial listing →
  • Completed NCT NCT04765436

    PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64

    Not yet reported Providence Therapeutics Holdings Inc. 60 participants Est. completion 2022-03-30 1 site
    Other conditions: Covid19 Vaccine
    View official trial listing →
  • Status unknown NCT NCT04769258

    Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD)

    Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) 1380 participants Est. completion 2022-06-01
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Terminated NCT NCT04770649

    Vaccine Observation to Include All Communities for Equitable Science

    Persephone Biosciences 15 participants Est. completion 2022-12-31 1 site
    Other conditions: Vaccine Response Impaired, Vaccine Adverse Reaction
    View official trial listing →
  • Completed NCT NCT04771559

    Evaluation of the Effect and Side Effect Profile of Covid-19 Vaccine in Cancer Patients

    Not yet reported Bezmialem Vakif University 1500 participants Est. completion 2021-07-01 5 sites
    Other conditions: Covid19, Cancer
    View official trial listing →
  • Terminated NCT NCT04773067

    A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers

    Not yet reported United Biomedical Inc., Asia 3877 participants Est. completion 2022-03-08 12 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04773665

    Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a

    Not yet reported VBI Vaccines Inc. 114 participants Est. completion 2022-11-14 4 sites Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04775069

    Antibody Response to COVID-19 Vaccines in Liver Disease Patients

    Not yet reported Humanity & Health Medical Group Limited 232 participants Est. completion 2023-09-30 1 site
    Other conditions: Chronic Liver Disease
    View official trial listing →
  • Completed NCT NCT04775563

    COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients

    National Institute of Medical Sciences and Nutrition, Salvador Zubiran 891 participants Est. completion 2021-10-01 1 site
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04776005

    COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies

    Assistance Publique - Hôpitaux de Paris 500 participants Est. completion 2024-02 2 sites
    Other conditions: Solid Tumor, Hematologic Malignancy, Thoracic Cancer, Cancer, Treatment-Related, Vaccine Response Impaired
    View official trial listing →
  • Completed NCT NCT04776317

    Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 81 participants Est. completion 2023-09-15 4 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04779138

    Increasing Vaccine Uptake in Underresourced Public Housing Areas

    Not yet reported Charles Drew University of Medicine and Science 462 participants Est. completion 2024-04-01 1 site Stand-alone
    Other conditions: Coronavirus, Vaccine Refusal
    View official trial listing →
  • Completed NCT NCT04784689

    Host Immune Response to Novel RNA COVID-19 Vaccination

    The University of Texas Health Science Center at San Antonio 50 participants Est. completion 2022-05-18 1 site
    Other conditions: COVID-19 Vaccine, Cancer
    View official trial listing →
  • Completed NCT NCT04785144

    Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 135 participants Est. completion 2022-07-05 4 sites
    Other conditions: COVID-19, COVID-19 Immunisation
    View official trial listing →
  • Completed NCT NCT04792567

    Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC)

    Not yet reported Novartis Pharmaceuticals 41 participants Est. completion 2022-08-15 10 sites
    Other conditions: Secondary Progressive Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT04794829

    Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination

    National Institute of Allergy and Infectious Diseases (NIAID) 75 participants Est. completion 2026-07-28 1 site
    Other conditions: Influenza, COVID-19
    View official trial listing →
  • Status unknown NCT NCT04794946

    Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis

    Not yet reported Institute of Liver and Biliary Sciences, India 2200 participants Est. completion 2022-03-19 1 site
    Other conditions: Liver Cirrhosis
    View official trial listing →
  • Status unknown NCT NCT04798001

    Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults

    Not yet reported Meissa Vaccines, Inc. 130 participants Est. completion 2022-10-31 2 sites
    Other conditions: Covid19
    View official trial listing →
  • Active, not recruiting NCT NCT04798625

    Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication

    Diakonhjemmet Hospital 2300 participants Est. completion 2027-02-15 2 sites
    Other conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Spondyloarthritis, Crohn Disease, Ulcerative Colitis, Autoimmune Hepatitis, Liver Transplant; Complications
    View official trial listing →
  • Terminated NCT NCT04799392

    NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons

    Not yet reported NOWDiagnostics, Inc. 50 participants Est. completion 2021-10-28 5 sites Stand-alone
    Other conditions: COVID-19, SARS-CoV-2, Coronavirus
    View official trial listing →
  • Status unknown NCT NCT04800133

    Covid-19 Vaccination in Adolescents and Children

    Not yet reported The University of Hong Kong 1018 participants Est. completion 2025-03-31 1 site
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04801030

    COVID-19 Vaccine Hesitancy Among African Americans

    Not yet reported Meharry Medical College 300 participants Est. completion 2022-09-30 1 site
    Other conditions: Covid19, Vaccine Refusal, Communication
    View official trial listing →
  • Status unknown NCT NCT04802278

    Gestational Immunity for Transfer

    National University Hospital, Singapore 120 participants Est. completion 2021-12-01 1 site
    Other conditions: Covid19, Breastfeeding, Vaccine Exposure Via Breast Milk
    View official trial listing →
  • Completed NCT NCT04805216

    Covid-19 Vaccine Response in Immunocompromised Haematology Patients

    University Hospitals of North Midlands NHS Trust 75 participants Est. completion 2022-07-31 1 site
    Other conditions: Covid19, Haematological Disorders, Immune Suppression
    View official trial listing →
  • Completed NCT NCT04806113

    COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 220 participants Est. completion 2022-06-15 1 site
    Other conditions: Covid19, Rheumatic Diseases, Rheumatoid Arthritis, SLE
    View official trial listing →
  • Status unknown NCT NCT04809948

    Effects of COVID 19 Vaccine on Egyptian Population

    Assiut University 800 participants Est. completion 2021-12-30
    Other conditions: COVID 19 Vaccine
    View official trial listing →
  • Status unknown NCT NCT04813562

    Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells)

    Not yet reported Jiangsu Province Centers for Disease Control and Prevention 480 participants Est. completion 2022-07-30 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04816019

    A Study of Intranasal ChAdOx1 nCOV-19

    Not yet reported University of Oxford 42 participants Est. completion 2022-09-30 1 site Stand-alone
    Other conditions: Coronavirus
    View official trial listing →
  • No Longer Available NCT NCT04817657

    Pre-approval Access for Janssen's COVID Vaccine VAC31518 for Treating Physician Use

    Janssen Research & Development, LLC
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04818801

    Safety, Reactogenicity and Immunogenicity Study of ReCOV

    Not yet reported Jiangsu Rec-Biotechnology Co., Ltd. 100 participants Est. completion 2022-05-05 2 sites Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04818892

    Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease

    University of Wisconsin, Madison 222 participants Est. completion 2022-11-11 1 site
    Other conditions: IBD, Covid19 Vaccine
    View official trial listing →
  • Status unknown NCT NCT04822012

    Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid

    Meir Medical Center 50 participants Est. completion 2021-06-01 1 site
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Completed NCT NCT04824651

    Covid-19 Vaccine Cohort in Specific Populations

    ANRS, Emerging Infectious Diseases 6922 participants Est. completion 2024-12-11 3 sites
    Other conditions: Immune Deficiency
    View official trial listing →
  • Status unknown NCT NCT04828460

    Monitoring of COVID-19 Vaccine Response in Organ Transplant Patients

    University Hospital, Strasbourg, France 3500 participants Est. completion 2023-02 1 site
    Other conditions: Covid19, Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT04832932

    The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes

    Mebo Research, Inc. 2000 participants Est. completion 2025-01-05 5 sites
    Other conditions: COVID-19 Vaccines
    View official trial listing →
  • Completed NCT NCT04837651

    Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab

    Dragonfly Research, LLC 48 participants Est. completion 2021-07-01 1 site
    Other conditions: Multiple Sclerosis, Demyelinating Autoimmune Diseases, CNS, Autoimmune Diseases of the Nervous System, Nervous System Diseases, Demyelinating Diseases, Autoimmune Diseases, Immune System Diseases, Pathologic Processes
    View official trial listing →
  • Status unknown NCT NCT04838080

    Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo

    Not yet reported Kocak Farma 38 participants Est. completion 2021-10-20 1 site Stand-alone
    Other conditions: COVID-19 Vaccine
    View official trial listing →
  • Completed NCT NCT04838795

    Sisonke (Together): OPEN LABEL TRIAL COVID-19

    Not yet reported Wits Health Consortium (Pty) Ltd 477102 participants Est. completion 2022-03-31 31 sites
    Other conditions: SARS (Severe Acute Respiratory Syndrome)
    View official trial listing →
  • Completed NCT NCT04839146

    Safety and Tolerability of COVID-19 Vaccine (ABNCoV2)

    Not yet reported Radboud University Medical Center 45 participants Est. completion 2022-02-25 1 site
    Other conditions: Covid19, Severe Acute Respiratory Syndrome, SARS-CoV-2 Infection
    View official trial listing →
  • Completed NCT NCT04840992

    Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation

    Not yet reported, Not yet reported CanSino Biologics Inc. 840 participants Est. completion 2022-08-09 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04843774

    Vaccine-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA)

    NYU Langone Health 64 participants Est. completion 2023-04-18 2 sites
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT04843917

    Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine

    Hospital Italiano de Buenos Aires 100 participants Est. completion 2023-08-09 1 site
    Other conditions: Coronavirus 2019, Healthcare Workers, Vaccine
    View official trial listing →
  • Terminated NCT NCT04844346

    Plant Stanol Esters and COVID-19 Vaccination Response

    Not yet reported Maastricht University Medical Center 48 participants Est. completion 2022-01-11 1 site Stand-alone
    Other conditions: Overweight and Obesity
    View official trial listing →
  • Completed NCT NCT04845048

    Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine

    Butantan Institute 2549 participants Est. completion 2023-03-13 3 sites
    Other conditions: SARS-CoV-2 Acute Respiratory Disease
    View official trial listing →
  • Withdrawn NCT NCT04845191

    COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-14
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04845997

    COVID-19 Vaccination in Patients With Rheumatic Diseases

    Sociedad Argentina de Reumatologia 3000 participants Est. completion 2023-12-31 2 sites
    Other conditions: Rheumatic Diseases
    View official trial listing →
  • Completed NCT NCT04847596

    A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab

    Novartis Pharmaceuticals 25 participants Est. completion 2022-02-18 5 sites
    Other conditions: Relapsing Multiple Sclerosis
    View official trial listing →
  • Withdrawn NCT NCT04848467

    COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

    Not yet reported Bayer Est. completion 2022-11-15
    Other conditions: SARS-CoV-2 Infection, Coronavirus Disease 2019 (COVID-19)
    View official trial listing →
  • Completed NCT NCT04848493

    National Project on Vaccines, COVID-19 and Frail Patients

    Azienda USL Reggio Emilia - IRCCS 747 participants Est. completion 2022-12-31 12 sites
    Other conditions: COVID-19, Solid Tumor, Hematologic Diseases, Neurologic Disorder, Rheumatic Diseases
    View official trial listing →
  • Status unknown NCT NCT04852705

    A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)

    Not yet reported Shenzhen Kangtai Biological Products Co., LTD 28000 participants Est. completion 2022-11
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04852978

    COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers

    Not yet reported Regeneron Pharmaceuticals 295 participants Est. completion 2022-11-21 6 sites
    Other conditions: Healthy, Chronic Stable Illness
    View official trial listing →
  • Completed NCT NCT04854408

    Evaluation of the Effect of Coronavac Vaccine (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 Vaccine) on Healthcare Workers' Menstrual Patterns

    Kanuni Sultan Suleyman Training and Research Hospital 300 participants Est. completion 2021-05-09 1 site
    Other conditions: Covid19, Vaccine Reaction, Coronavirus, Menstrual Problem, Endometrium
    View official trial listing →
  • Withdrawn NCT NCT04854876

    Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune System Enhancer Along With Vaccination Against COVID-19

    Not yet reported Royal College of Surgeons in Ireland - Medical University of Bahrain Est. completion 2021-08-30 Stand-alone
    Other conditions: SARS-COV 2, Covid19
    View official trial listing →
  • Completed NCT NCT04858568

    Immune Responses to COVID-19 Vaccination in Lymphoma Patients

    University Hospital Southampton NHS Foundation Trust 592 participants Est. completion 2024-01-31 9 sites
    Other conditions: Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Primary Mediastinal B Cell Lymphoma, High-grade B-cell Lymphoma, Burkitt Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma, Nodular Lymphocyte Predominant Hodgkin Lymphoma, Peripheral T-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT04858607

    Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals

    Medical University of Graz 373 participants Est. completion 2023-01-20 1 site
    Other conditions: Covid19, Immunosuppression
    View official trial listing →
  • Completed NCT NCT04860297

    A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants

    Not yet reported ModernaTX, Inc. 234 participants Est. completion 2023-05-22 15 sites Stand-alone
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Status unknown NCT NCT04860908

    COVID 19 ANTOBODIES IN PREGNANT WOMEN AND THEIR CONNECTION TO BETA CELL FUNCTION IN THE FETUS

    Maaynei Hayesha Medical Center 100 participants Est. completion 2022-07-01 1 site
    Other conditions: Generation of Anti COVID-19 Antibodies in a Fetus, Whose Mother Was Exposed to COVID or Was Vaccinated During Pregnancy
    View official trial listing →
  • Status unknown NCT NCT04863638

    A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated

    Not yet reported China National Biotec Group Company Limited 4400 participants Est. completion 2024-03-31 1 site Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04864561

    COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222

    Not yet reported Valneva Austria GmbH 4034 participants Est. completion 2023-03-13 31 sites
    Other conditions: SARS-CoV-2 Virus Infection
    View official trial listing →
  • Completed NCT NCT04865133

    Efficacy and Safety of COVID-19 Vaccine in Cancer Patients

    Mayo Clinic 89 participants Est. completion 2022-09-08 1 site
    Other conditions: COVID-19 Infection, Malignant Solid Neoplasm
    View official trial listing →
  • Status unknown NCT NCT04865900

    Prevalence of Perimyocarditis After Covid-19 Vaccine

    Hillel Yaffe Medical Center 500 participants Est. completion 2022-04 1 site
    Other conditions: Perimyocarditis, Covid19
    View official trial listing →
  • Status unknown NCT NCT04868448

    COVID-19 Vaccine Effectiveness Among Health Workers in Georgia

    National Center for Disease control and Public Health 1600 participants Est. completion 2022-08-01 6 sites
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04869358

    Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab

    Not yet reported Novartis Pharmaceuticals 34 participants Est. completion 2023-06-13 6 sites
    Other conditions: Relapsing Multiple Sclerosis
    View official trial listing →
  • Terminated NCT NCT04870411

    Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics

    Assistance Publique - Hôpitaux de Paris 78 participants Est. completion 2022-03-13 1 site
    Other conditions: Autoimmune Diseases, Inflammatory Disorder
    View official trial listing →
  • Status unknown NCT NCT04871165

    Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals

    Vilnius University 3270 participants Est. completion 2024-03-01 1 site
    Other conditions: Hematologic Neoplasms, COVID-19 Vaccines
    View official trial listing →
  • Status unknown NCT NCT04876885

    The Future of Viral Communications: Video-Based Health Promotion Strategies for COVID-19 Vaccinations

    Not yet reported McMaster University 100 participants Est. completion 2021-06-06
    Other conditions: Health Promotion, Health Education, COVID-19 Vaccines
    View official trial listing →
  • Status unknown NCT NCT04877496

    Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab.

    Insel Gruppe AG, University Hospital Bern 425 participants Est. completion 2021-10-31 1 site
    Other conditions: COVID19 Vaccination, Rituximab, Immunosuppression
    View official trial listing →
  • Terminated NCT NCT04878211

    A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab

    Not yet reported Novartis Pharmaceuticals 24 participants Est. completion 2023-04-14 7 sites Stand-alone
    Other conditions: Relapsing Multiple Sclerosis (RMS)
    View official trial listing →
  • Completed NCT NCT04881396

    Response of Haemodialysis Patients to BNT162b2 mRNA Cov-19 Vaccine

    Hospices Civils de Lyon 99 participants Est. completion 2022-02-15 2 sites
    Other conditions: COVID-19 Vaccines, Hemodialysis Complication
    View official trial listing →
  • Status unknown NCT NCT04885764

    Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University

    Not yet reported, Not yet reported Ain Shams University 4000 participants Est. completion 2021-12-01 1 site
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04885907

    Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients

    Not yet reported University Health Network, Toronto 120 participants Est. completion 2021-08-30 2 sites
    Other conditions: Vaccine Response Impaired, Immune Suppression, Covid19
    View official trial listing →
  • Completed NCT NCT04887129

    Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)

    Not yet reported University of Rochester 392 participants Est. completion 2024-03-31 1 site Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04892459

    Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector)

    Not yet reported Jiangsu Province Centers for Disease Control and Prevention 300 participants Est. completion 2021-12-25 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04894435

    Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity

    Not yet reported Canadian Immunization Research Network 669 participants Est. completion 2023-06-16 8 sites
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT04894448

    Immunogenicity of COVID-19 Vaccination in PLWH

    CIHR Canadian HIV Trials Network 500 participants Est. completion 2023-07-31 3 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Status unknown NCT NCT04895007

    Comparative Evaluation of Covid-19 Vaccines Response

    Karamanoğlu Mehmetbey University 1500 participants Est. completion 2022-06-01 4 sites
    Other conditions: COVID-19 Vaccines
    View official trial listing →
  • Status unknown NCT NCT04900467

    Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine

    Not yet reported Assistance Publique - Hôpitaux de Paris 418 participants Est. completion 2022-01 1 site Stand-alone
    Other conditions: Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose
    View official trial listing →
  • Completed NCT NCT04904744

    Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of COVID-19 Vaccination

    Not yet reported Children's Hospital Medical Center, Cincinnati 1235 participants Est. completion 2021-12-10 1 site
    Other conditions: Health Care Utilization, Vaccine Preventable Disease
    View official trial listing →
  • Completed NCT NCT04910295

    Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients

    Seoul National University Hospital 112 participants Est. completion 2022-12-31 1 site
    Other conditions: Cancer, Covid19
    View official trial listing →
  • Status unknown NCT NCT04910971

    Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year

    LifeBridge Health 60 participants Est. completion 2022-07-28 1 site
    Other conditions: COVID-19 Vaccine, Corona Virus Infection, Vaccine Adverse Reaction, Vaccine Response, Inflammation, Thrombosis
    View official trial listing →
  • Completed NCT NCT04912700

    The Impact of Vaccination on Severity of Illness in COVID-19

    Corewell Health East 11834 participants Est. completion 2021-06-07 1 site
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04918888

    COVID-19 Vaccination in Oncologic Patients

    Krankenhaus Barmherzige Schwestern Linz 1150 participants Est. completion 2021-09-30 2 sites
    Other conditions: Covid19, Oncologic Disorders
    View official trial listing →
  • Completed NCT NCT04922944

    Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients

    Huntington Memorial Hospital 167 participants Est. completion 2022-03-01 1 site
    Other conditions: Covid19, Vaccine Reaction
    View official trial listing →
  • Active, not recruiting NCT NCT04924803

    Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs

    Not yet reported NDRI-USA, Inc. 545 participants Est. completion 2026-02-27 1 site
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04927065

    A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants

    Not yet reported, Not yet reported ModernaTX, Inc. 5161 participants Est. completion 2023-11-17 23 sites
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Withdrawn NCT NCT04930770

    Study About the Response to the Administration of a Third Dose of mRNA-1273 Vaccine (COVID-19 Vaccine Moderna) in Renal Transplants With Immunological Failure Initial to Vaccination

    Not yet reported Maria Joyera Rodríguez Est. completion 2022-03-01
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04932863

    BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment

    Ente Ospedaliero Ospedali Galliera 300 participants Est. completion 2023-03-15 1 site
    Other conditions: Neoplasms, Cancer, Treatment-Related
    View official trial listing →
  • Status unknown NCT NCT04939155

    Methylation Effects of COV-19 Infection and Vaccinations

    TruDiagnostic 60 participants Est. completion 2022-03-10 1 site
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04939506

    COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana

    Not yet reported Xavier University of Louisiana. 377 participants Est. completion 2024-01-25 1 site Stand-alone
    Other conditions: Covid19, Vaccine Refusal, Vaccine Hesitancy
    View official trial listing →
  • Completed NCT NCT04939519

    SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers

    Not yet reported University of Utah 65300 participants Est. completion 2023-02-28 1 site
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04942405

    Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine

    Not yet reported Health Institutes of Turkey 1290 participants Est. completion 2024-02-01 29 sites
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04944381

    Study of Ameliorating Effect of COVID-19 mRNA Vaccine in Individuals Immunized With Inactivated Vaccine

    Not yet reported Qihan Li 112 participants Est. completion 2022-08-02
    Other conditions: SARS-CoV-2 Acute Respiratory Disease
    View official trial listing →
  • Completed NCT NCT04944433

    Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients

    Hospital Italiano de Buenos Aires 950 participants Est. completion 2022-08-04 1 site
    Other conditions: Coronavirus Disease 2019 Vaccines, Renal Dialysis
    View official trial listing →
  • Completed NCT NCT04949490

    A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects

    Not yet reported BioNTech SE 137 participants Est. completion 2022-09-16 4 sites
    Other conditions: COVID-19, SARS-CoV-2 Infection
    View official trial listing →
  • Status unknown NCT NCT04951323

    Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

    Not yet reported University of Liege 50 participants Est. completion 2023-01-01 1 site
    Other conditions: Coronavirus Disease 2019 (Covid19), Hematopoietic Neoplasms
    View official trial listing →
  • Completed NCT NCT04951388

    A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents

    Not yet reported Medigen Vaccine Biologics Corp. 399 participants Est. completion 2022-03-21 5 sites
    Other conditions: Covid19 Vaccine
    View official trial listing →
  • Completed NCT NCT04952376

    Equitable Access to COVID-19 Vaccines

    Not yet reported Mayo Clinic 1722 participants Est. completion 2021-06-10 1 site Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04954131

    Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China

    Not yet reported Zhejiang Clover Biopharmaceuticals, Inc. 766 participants Est. completion 2022-11-15 2 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04954287

    Phase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and Adolescents

    Not yet reported CyanVac LLC 72 participants Est. completion 2023-06-10 4 sites
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04954469

    B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency

    Not yet reported, Not yet reported University Hospital Tuebingen 54 participants Est. completion 2023-04-30 3 sites
    Other conditions: Immune Deficiency Disease
    View official trial listing →
  • Completed NCT NCT04956562

    Effect of Sinovac on Survival in Intensive Care Unit

    Sisli Hamidiye Etfal Training and Research Hospital 96 participants Est. completion 2021-05-15 1 site
    Other conditions: Survival, Intensive Care Unit
    View official trial listing →
  • Terminated NCT NCT04958304

    Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study

    ModernaTX, Inc. 20 participants Est. completion 2023-09-22 1 site
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Completed NCT NCT04958954

    Post-Marketing Safety Study of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in the United States

    ModernaTX, Inc. 50000000 participants Est. completion 2023-06-30 1 site
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Status unknown NCT NCT04961229

    Booster Dose of COVID-19 Vaccine for Kidney Transplant Recipients Without Adequate Humoral Response

    Not yet reported dafna yahav 504 participants Est. completion 2022-07
    Other conditions: COVID-19 Acute Respiratory Distress Syndrome, Immunosuppression
    View official trial listing →
  • Completed NCT NCT04962906

    Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes

    Not yet reported Ministerio de Salud de Ciudad Autónoma de Buenos Aires 192 participants Est. completion 2021-08-15 1 site
    Other conditions: COVID-19 Vaccines
    View official trial listing →
  • Terminated NCT NCT04963790

    Enabling Family Physicians to Reduce Vaccine Hesitancy and Increase Covid-19 Vaccine Uptake

    Not yet reported Hopital Montfort 12 participants Est. completion 2023-07-14 1 site Stand-alone
    Other conditions: Covid19, COVID-19 Vaccine
    View official trial listing →
  • Completed NCT NCT04967742

    A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine

    Not yet reported United Biomedical Inc., Asia 50 participants Est. completion 2021-10-31 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04969601

    Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings

    Not yet reported, Not yet reported Assistance Publique - Hôpitaux de Paris 76 participants Est. completion 2024-03-01 2 sites
    Other conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT04973449

    Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults

    Not yet reported, Not yet reported AstraZeneca 2843 participants Est. completion 2022-08-02 35 sites
    Other conditions: COVID-19, SARS-CoV-2
    View official trial listing →
  • Completed NCT NCT04974164

    Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic

    Sinovac Research and Development Co., Ltd. 1400 participants Est. completion 2021-12-13 10 sites
    Other conditions: COVID-19
    View official trial listing →
  • Active, not recruiting NCT NCT04977024

    SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

    Not yet reported GeoVax, Inc. 63 participants Est. completion 2027-12-31 6 sites
    Other conditions: COVID-19 Infection, Hematopoietic and Lymphoid System Neoplasm, Leukemia, Lymphoma, Plasma Cell Myeloma
    View official trial listing →
  • Completed NCT NCT04981392

    Trusted Messengers: Intervention to Promote COVID-19 Vaccination

    Not yet reported University of Massachusetts, Worcester 21844 participants Est. completion 2023-10-25 1 site
    Other conditions: Covid19, Vaccination
    View official trial listing →
  • Terminated NCT NCT04981405

    Real-world Evidence of COVID-19 Vaccines Effectiveness

    Ivan S Moiseev 182 participants Est. completion 2022-07-19 2 sites
    Other conditions: COVID-19 Pneumonia
    View official trial listing →
  • Status unknown NCT NCT04983537

    Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population

    Not yet reported Ministerio de Salud de Ciudad Autónoma de Buenos Aires 120 participants Est. completion 2021-09-26 2 sites
    Other conditions: COVID-19 Vaccines
    View official trial listing →
  • Status unknown NCT NCT04988048

    Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina

    Not yet reported Ministry of Public Health, Argentina 1760 participants Est. completion 2022-02-15 4 sites
    Other conditions: COVID-19 VACCINE, Covid19
    View official trial listing →
  • Status unknown NCT NCT04992182

    Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster

    Not yet reported Universidad del Desarrollo 534 participants Est. completion 2022-06-30 2 sites
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04992195

    Impact of COVID-19 Vaccines on Cerebrovascular Health

    Chinese University of Hong Kong 415 participants Est. completion 2026-03-31 1 site
    Cardiovascular disease Other conditions: Dementia, Brain Ischemia, Alzheimer Disease, Brain Diseases, Major Adverse Cardiovascular Event, Arterial Thromboembolism, Venous Thromboembolism
    View official trial listing →
  • Completed NCT NCT04993209

    Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil

    Not yet reported Butantan Institute 320 participants Est. completion 2022-11-04 1 site
    Other conditions: Coronavirus Infections, Healthy
    View official trial listing →
  • Withdrawn NCT NCT04993326

    Advancing DSME/S and COVID-19 Prevention and Protection Through "emPOWERed to Change" Program

    Not yet reported Charles Drew University of Medicine and Science Est. completion 2023-02-28
    Type 2 diabetes Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04998240

    Mix and Match Heterologous Prime-Boost Study Using Approved COVID-19 Vaccines

    Not yet reported International Vaccine Institute 360 participants Est. completion 2024-02-28 2 sites
    Other conditions: Covid19
    View official trial listing →
  • Terminated NCT NCT05000216

    COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 258 participants Est. completion 2024-03-28 29 sites Stand-alone
    Other conditions: Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris, Multiple Sclerosis (MS), Systemic Sclerosis (SSc), Pediatric SLE, Juvenile Idiopathic Arthritis (JIA), Juvenile Dermatomyositis (JDM), Pediatric-Onset Multiple Sclerosis (POMS)
    View official trial listing →
  • Completed NCT NCT05004181

    Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

    Not yet reported BioNTech SE 1380 participants Est. completion 2023-10-04 35 sites
    Other conditions: SARS-CoV-2 Infection, COVID-19, SARS-CoV-2 Acute Respiratory Disease, SARS (Disease)
    View official trial listing →
  • Completed NCT NCT05007080

    A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive

    Not yet reported Janssen Vaccines & Prevention B.V. 304 participants Est. completion 2023-08-14 18 sites
    Other conditions: Coronavirus Disease-2019 (COVID-19) Prevention
    View official trial listing →
  • Completed NCT NCT05007860

    Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia

    Massachusetts General Hospital 36 participants Est. completion 2023-06-30 1 site
    Other conditions: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT05009030

    Anti-SARS-COV2 Vaccination Study in Lung Cancer Patients

    Fundación GECP 794 participants Est. completion 2022-03-28 51 sites
    Other conditions: Lung Cancer, Covid19
    View official trial listing →
  • Status unknown NCT NCT05012800

    Safety and Immunogenicity of COVID-19 Vaccine Administered in Older Adults

    Not yet reported Beijing 302 Hospital 300 participants Est. completion 2022-09-30 1 site Stand-alone
    Other conditions: COVID-19 Vaccine, Older Adults
    View official trial listing →
  • Withdrawn NCT NCT05013983

    Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents

    Not yet reported, Not yet reported WestVac Biopharma Co., Ltd. Est. completion 2025-12 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Enrolling by invitation NCT NCT05015881

    Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder

    Not yet reported, Not yet reported University of Pennsylvania 20 participants Est. completion 2027-12 1 site
    Alcohol use disorder
    View official trial listing →
  • Terminated NCT NCT05016622

    Booster Dose Trial

    Not yet reported Montefiore Medical Center 106 participants Est. completion 2023-05-21 1 site
    Other conditions: Cancer
    View official trial listing →
  • Status unknown NCT NCT05017805

    COVID-19 Vaccines in Patients With Chronic Liver Disease

    Not yet reported Beijing 302 Hospital 300 participants Est. completion 2025-08-15 1 site Stand-alone
    Other conditions: Liver Disease Chronic
    View official trial listing →
  • Completed NCT NCT05020145

    COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States

    Pfizer 1277747 participants Est. completion 2021-12-17 1 site
    Other conditions: Immunocompromised, Immunosuppressed, Covid-19, SARS-COV-2, SARS-COV-2 Infection, Breakthrough Infection
    View official trial listing →
  • Terminated NCT NCT05022329

    COVID-19 Vaccine Boosters in Patients With CKD

    Not yet reported, Not yet reported Sunnybrook Health Sciences Centre 273 participants Est. completion 2022-11-15 3 sites Stand-alone
    Chronic kidney disease Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05022472

    Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California

    Not yet reported Britt Skaathun 1051 participants Est. completion 2024-03-29 6 sites Stand-alone
    Other conditions: Vaccine Refusal, Covid19
    View official trial listing →
  • Completed NCT NCT05027464

    Developing and Testing a COVID-19 Vaccination Acceptance Intervention

    Not yet reported VA Office of Research and Development 338718 participants Est. completion 2024-09-30 2 sites Stand-alone
    Other conditions: COVID-19 Vaccination
    View official trial listing →
  • Completed NCT NCT05028361

    Simultaneous mRNA COVID-19 and IIV4 Vaccination Study

    Not yet reported Duke University 348 participants Est. completion 2023-06-15 3 sites
    Other conditions: Quality of Life, Injection Site Reaction, Adverse Drug Event, Systemic Reaction
    View official trial listing →
  • Active, not recruiting NCT NCT05032976

    Korea Comirnaty Post-marketing Surveillance

    Pfizer 12000 participants Est. completion 2027-01-24 1 site
    Other conditions: COVID-19, Vaccines, Adverse Effects, SARS-CoV-2, Safety
    View official trial listing →
  • Status unknown NCT NCT05033834

    Covid-19 Infection in After Vaccination

    Assiut University 100 participants Est. completion 2022-12-31 3 sites
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT05033847

    Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above

    Not yet reported National Vaccine and Serum Institute, China 1800 participants Est. completion 2024-01 1 site Stand-alone
    Other conditions: COVID-19 Pneumonia, Coronavirus Infections
    View official trial listing →
  • Withdrawn NCT NCT05035238

    Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial

    Not yet reported Health Institutes of Turkey Est. completion 2021-10-01 1 site
    Other conditions: Covid19
    View official trial listing →
  • Terminated NCT NCT05037266

    Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 27 participants Est. completion 2024-01-29 10 sites Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT05043129

    Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection

    The Second Affiliated Hospital of Chongqing Medical University 200 participants Est. completion 2022-09-04 1 site
    Other conditions: HIV Infections, Covid19
    View official trial listing →
  • Status unknown NCT NCT05043246

    Safety and Immune Response of COVID-19 Vaccination in Patients With Basic Disease

    The Second Affiliated Hospital of Chongqing Medical University 2300 participants Est. completion 2023-08-01 1 site
    Other conditions: Diseases, Chronic, Covid19, Adverse Reaction to Vaccine
    View official trial listing →
  • Status unknown NCT NCT05043272

    Safety and Immune Response of COVID-19 Vaccination in Overweight People With Excessive BMI

    The Second Affiliated Hospital of Chongqing Medical University 450 participants Est. completion 2022-08-01 1 site
    Other conditions: Covid19, Overweight
    View official trial listing →
  • Status unknown NCT NCT05043311

    The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.

    Not yet reported, Not yet reported Sinocelltech Ltd. 300 participants Est. completion 2023-01-01 1 site
    Other conditions: COVID-19, SARS-CoV-2 Infection
    View official trial listing →
  • Completed NCT NCT05047718

    Factors Influencing the COVID-19 Vaccine Immune Response According to Age and Presence or Not of a Past History of COVID-19

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 54 participants Est. completion 2023-02-28 2 sites Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT05047822

    Oxford/AstraZeneca COVID-19 Vaccine Effectiveness in England

    AstraZeneca 18373714 participants Est. completion 2023-01-27 1 site
    Other conditions: Covid-19 Infection
    View official trial listing →
  • Completed NCT NCT05048849

    A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study

    Not yet reported Medigen Vaccine Biologics Corp. 274 participants Est. completion 2022-04-12 11 sites
    Other conditions: Covid19 Vaccine
    View official trial listing →
  • Withdrawn NCT NCT05048940

    Efficacy, Safety, and Immunogenicity of Vaccine Reimmunization With a Third Homologous Versus Heterologous Dose Against COVID-19 in Patients Undergoing Solid Organ Transplantation.

    Not yet reported Instituto de Investigación Marqués de Valdecilla Est. completion 2021-09-01 1 site Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT05050474

    Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)

    Not yet reported Livzon Pharmaceutical Group Inc. 43 participants Est. completion 2022-02-18 1 site Stand-alone
    Other conditions: COVID19
    View official trial listing →
  • Status unknown NCT NCT05051605

    Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation

    Ain Shams University 50 participants Est. completion 2023-11-30 1 site
    Other conditions: Liver Transplant
    View official trial listing →
  • Completed NCT NCT05054621

    Immunogenicity of COVID-19 Vaccine on Heterologous Schedule

    Not yet reported Chang Gung Memorial Hospital 100 participants Est. completion 2022-08-31 1 site
    Other conditions: Covid-19, Vaccine, Immunogenicity, Reactogenicity, Healthy
    View official trial listing →
  • Completed NCT NCT05057182

    Third Dose of mRNA Vaccination to Boost COVID-19 Immunity (mBoost Study)

    Not yet reported The University of Hong Kong 300 participants Est. completion 2024-12-31 1 site
    Other conditions: COVID 19 Vaccine
    View official trial listing →
  • Terminated NCT NCT05057897

    A Study of AZD1222, a Vaccine for the Prevention of COVID-19 in Immunocompromised Adults

    Not yet reported AstraZeneca 34 participants Est. completion 2023-04-19 4 sites
    Other conditions: COVID-19, SARS-CoV-2
    View official trial listing →
  • Status unknown NCT NCT05059106

    EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19

    Not yet reported, Not yet reported Federal University of Espirito Santo 29637 participants Est. completion 2022-10-30 1 site
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Completed NCT NCT05062525

    Immune Response to COVID-19 Vaccine in Immunotherapy (IO) and Non-IO Treated Cancer Patients

    University Health Network, Toronto 53 participants Est. completion 2021-09-28 1 site
    Other conditions: COVID-19, Cancer
    View official trial listing →
  • Completed NCT NCT05067894

    Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine

    Not yet reported PT Bio Farma 54 participants Est. completion 2022-08-06 1 site
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT05067959

    Covid-19 Vaccine Responses in Patients With Inflammatory Bowel Diseases

    Rabin Medical Center 284 participants Est. completion 2022-03 1 site
    Other conditions: IBD, Covid19
    View official trial listing →
  • Status unknown NCT NCT05069129

    Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above

    Not yet reported, Not yet reported National Vaccine and Serum Institute, China 1848 participants Est. completion 2024-02 1 site Stand-alone
    Other conditions: COVID-19 Pneumonia, Coronavirus Infections
    View official trial listing →
  • Completed NCT NCT05074706

    Evaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Center Study

    University of Milano Bicocca 700 participants Est. completion 2022-06-15 1 site
    Other conditions: Hematologic Diseases
    View official trial listing →
  • Status unknown NCT NCT05075044

    Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected

    Not yet reported China National Biotec Group Company Limited 400 participants Est. completion 2022-12-30 1 site Stand-alone
    Other conditions: HIV Infections, COVID-19
    View official trial listing →
  • Status unknown NCT NCT05075057

    Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD

    Not yet reported China National Biotec Group Company Limited 400 participants Est. completion 2022-06-30 1 site Stand-alone
    Other conditions: COVID-19, Chronic Bronchitis, Copd
    View official trial listing →
  • Status unknown NCT NCT05075083

    Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD

    Not yet reported China National Biotec Group Company Limited 400 participants Est. completion 2022-06-30 1 site Stand-alone
    Other conditions: COVID-19, Chronic Bronchitis, COPD
    View official trial listing →
  • Completed NCT NCT05076227

    Effect of Different SARS-CoV-2 Vaccine Schedules and Vaccination Intervals on Reactogenicity and Humoral Immunogenicity

    Serge Thal 1206 participants Est. completion 2022-03-27 1 site
    Other conditions: SARS-CoV2 Infection, Immunisation Reaction, Antibody Hypersensitivity, Tolerance
    View official trial listing →
  • Completed NCT NCT05080218

    COVID-19 VaccinE Response in Rheumatology Patients

    Not yet reported Jeffrey Curtis 841 participants Est. completion 2024-05-28 8 sites
    Other conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis
    View official trial listing →
  • Completed NCT NCT05083065

    Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 Vaccine

    Università degli Studi dell'Insubria 369 participants Est. completion 2021-12-30 1 site
    Other conditions: COVID-19, Vaccine, Menstrual Irregularity, Menopausal Bleeding
    View official trial listing →
  • Status unknown NCT NCT05087368

    Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19)

    Not yet reported D'Or Institute for Research and Education 520 participants Est. completion 2022-04-01 3 sites Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT05091307

    A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults

    Not yet reported Janssen Vaccines & Prevention B.V. 861 participants Est. completion 2022-11-15 31 sites
    Other conditions: COVID-19 Prevention
    View official trial listing →
  • Completed NCT NCT05094609

    Phase 1 Trial of ChAd68 and Ad5 Adenovirus COVID-19 Vaccines Delivered by Aerosol

    Not yet reported McMaster University 36 participants Est. completion 2025-01-31 1 site
    Other conditions: COVID-19, SARS-CoV2 Infection
    View official trial listing →
  • Completed NCT NCT05096091

    International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)

    National Institute of Allergy and Infectious Diseases (NIAID) 5399 participants Est. completion 2025-08-19 11 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05096260

    Getting to Yes, Michigan! (G2YMI)

    Not yet reported University of Michigan 1180 participants Est. completion 2025-09-30 1 site Stand-alone
    Other conditions: COVID-19 Vaccines, COVID-19 Pandemic
    View official trial listing →
  • Completed NCT NCT05096832

    Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study

    Not yet reported Livzon Pharmaceutical Group Inc. 10381 participants Est. completion 2023-04-14 18 sites Stand-alone
    Other conditions: COVID-19 Pandemic
    View official trial listing →
  • Status unknown NCT NCT05096845

    Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III

    Not yet reported Livzon Pharmaceutical Group Inc. 22500 participants Est. completion 2023-06-14 25 sites Stand-alone
    Other conditions: COVID-19 Pandemic
    View official trial listing →
  • Completed NCT NCT05099497

    Supporting Audit and Feedback to Encourage Vaccine Uptake

    Not yet reported Women's College Hospital 600 participants Est. completion 2022-11-15 1 site Stand-alone
    Other conditions: Covid19 Vaccination, Vaccine Uptake
    View official trial listing →
  • Completed NCT NCT05104385

    Hacettepe University COVID-19 Vaccinated's Health Cohort- Students of Health Sciences

    Hacettepe University 1223 participants Est. completion 2023-12-07 1 site
    Other conditions: COVID-19 Pandemic, SARS-CoV2 Infection, Immunization; Infection, Health
    View official trial listing →
  • Status unknown NCT NCT05104437

    Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Wuhan) in Patients With Hypertension and/or Diabetes

    Not yet reported China National Biotec Group Company Limited 1440 participants Est. completion 2022-12 3 sites Stand-alone
    Other conditions: COVID-19 Pneumonia
    View official trial listing →
  • Completed NCT NCT05107271

    Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease

    Post Graduate Institute of Medical Education and Research, Chandigarh 252 participants Est. completion 2024-03-15 1 site
    Other conditions: COVID-19, Chronic Liver Failure, Cirrhosis, Liver, Portal Hypertension, Liver Transplant Disorder
    View official trial listing →
  • Completed NCT NCT05107375

    Clinical Study of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell) Combined With Influenza Vaccine

    Not yet reported Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 299 participants Est. completion 2022-03-04 1 site
    Other conditions: Coronavirus Disease 2019
    View official trial listing →
  • Completed NCT NCT05107557

    Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)

    Not yet reported Sinovac Biotech Co., Ltd 520 participants Est. completion 2022-07-14 2 sites Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05109559

    Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine

    Not yet reported, Not yet reported Mahidol University 690 participants Est. completion 2024-12 1 site Stand-alone
    Other conditions: SARS-CoV-2 Infection
    View official trial listing →
  • Completed NCT NCT05109598

    Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus(COVID-19) Vaccine (CHO Cell)

    Not yet reported Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 400 participants Est. completion 2023-04-06 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05112848

    A Study to Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19)

    Not yet reported Novavax 384 participants Est. completion 2022-11-30 7 sites
    Other conditions: SARS-CoV-2 Infection
    View official trial listing →
  • Completed NCT NCT05113472

    Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers

    Respiralab 1291 participants Est. completion 2021-05-31 1 site
    Other conditions: Adverse Drug Event
    View official trial listing →
  • Completed NCT NCT05119855

    Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

    Not yet reported Merck Sharp & Dohme LLC 165 participants Est. completion 2023-12-12 38 sites
    Other conditions: Papillomavirus Infections, Coronavirus Disease (COVID-19)
    View official trial listing →
  • Completed NCT NCT05121662

    COVID-19 Vaccine Biomarker Study in Multiple Sclerosis

    Columbia University 154 participants Est. completion 2025-02-13 1 site
    Other conditions: Multiple Sclerosis, COVID-19
    View official trial listing →
  • Status unknown NCT NCT05124171

    Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination

    Not yet reported Assistance Publique - Hôpitaux de Paris 247 participants Est. completion 2022-12 1 site
    Other conditions: COVID-19, Vaccine Reaction
    View official trial listing →
  • Completed NCT NCT05124223

    Analysis of Cardiac Damage Post Infection With SARS-CoV-2 and Post Vaccination Against COVID-19

    Sebastian Kelle 131 participants Est. completion 2021-08-31 1 site
    Other conditions: Myocarditis Acute
    View official trial listing →
  • Withdrawn NCT NCT05124561

    Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)

    Not yet reported CanSino Biologics Inc. Est. completion 2022-08-20 Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05126550

    The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine

    PT. Kimia Farma (Persero) Tbk 435 participants Est. completion 2022-11-30 4 sites
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05128643

    Clinical Study on the Immune Program of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell)

    Not yet reported Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 300 participants Est. completion 2022-10-12 1 site
    Other conditions: Coronavirus Disease 2019
    View official trial listing →
  • Status unknown NCT NCT05128721

    Evaluation of Inactivated Vaccine in Healthy Adults Against Coronavirus Disease of 2019 (COVID-19)

    Not yet reported National Research Centre, Egypt 72 participants Est. completion 2023-05-23 1 site
    Other conditions: COVID-19, Vaccine Reaction, Vaccine Adverse Reaction
    View official trial listing →
  • Completed NCT NCT05132907

    Safety and Immunogenicity of HDT-301 Targeting a SARS-CoV-2 Variant Spike Protein

    Not yet reported HDT Bio 48 participants Est. completion 2024-05-30 1 site
    Other conditions: SARS-CoV2 Infection
    View official trial listing →
  • Status unknown NCT NCT05133609

    COVID-19 VACCINE SAFETY AND EFFECTIVENESS

    Not yet reported, Not yet reported Federal University of Espirito Santo 550 participants Est. completion 2023-12-30 1 site
    Other conditions: SARS-CoV-2 Infection
    View official trial listing →
  • Completed NCT NCT05135585

    Evaluation of the Post-vaccination Immune Response to COVID-19 in the New Caledonian Population

    Not yet reported Institut Pasteur 680 participants Est. completion 2022-09-17 3 sites
    Other conditions: SARS-CoV-2 Acute Respiratory Disease
    View official trial listing →
  • Status unknown NCT NCT05137444

    Phase Ⅱ and Ⅲ Trial of a SARS-CoV-2 Vaccine LYB001

    Not yet reported, Not yet reported Yantai Patronus Biotech Co., Ltd. 1900 participants Est. completion 2023-05
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05142319

    Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]

    Not yet reported Tan Tock Seng Hospital 326 participants Est. completion 2024-05-07 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Terminated NCT NCT05142332

    PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXED

    Not yet reported University of California, San Francisco 541 participants Est. completion 2022-08-30 7 sites Stand-alone
    Other conditions: Covid-19 Vaccine, Vaccine Hesitancy
    View official trial listing →
  • Terminated NCT NCT05142501

    Observation of the Immune Response After COVID-19 Additional Vaccine Doses in Chronic Patients in Hemodialysis Therapy

    Fresenius Medical Care Deutschland GmbH 23 participants Est. completion 2022-09-02 11 sites
    Chronic kidney disease Other conditions: COVID-19, Hemodialysis
    View official trial listing →
  • Completed NCT NCT05144139

    A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above

    Not yet reported, Not yet reported Stemirna Therapeutics 480 participants Est. completion 2022-11-11 1 site
    Other conditions: COVID-19 Pandemic
    View official trial listing →
  • Status unknown NCT NCT05148949

    Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients

    Not yet reported Jiangsu Province Centers for Disease Control and Prevention 240 participants Est. completion 2023-03-10 6 sites
    Other conditions: COVID-19, Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT05148962

    Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers

    Not yet reported Gritstone bio, Inc. 45 participants Est. completion 2023-05-26 3 sites Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Withdrawn NCT NCT05155982

    A Clinical Trial of COVAC-1, a COVID-19 Vaccine, in Generally Healthy Adults

    Not yet reported University of Saskatchewan Est. completion 2023-10
    Other conditions: Severe Acute Respiratory Syndrome Coronavirus 2
    View official trial listing →
  • Withdrawn NCT NCT05156632

    Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above

    Not yet reported Sinovac Research and Development Co., Ltd. Est. completion 2023-02-20 Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05157191

    Safety of Pediatric COVID-19 Vaccination

    Duke University 299 participants Est. completion 2023-10-27 5 sites
    Other conditions: Pain, Injection Site Reaction, Adverse Drug Event
    View official trial listing →
  • Active, not recruiting NCT NCT05160636

    A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza

    Pfizer 999 participants Est. completion 2027-01-31 1 site
    Other conditions: COVID-19, Coronavirus Disease 2019, Influenza
    View official trial listing →
  • Status unknown NCT NCT05162482

    Combination Assessment Trial of COVID-19 Vaccines (COMBAT-COVID)

    Not yet reported Aga Khan University Hospital, Pakistan 1680 participants Est. completion 2024-06-30 3 sites
    Other conditions: COVID 19 Vaccine
    View official trial listing →
  • Status unknown NCT NCT05163652

    Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

    Not yet reported Chinese Academy of Medical Sciences 432 participants Est. completion 2022-10-30 1 site
    Other conditions: SARS-CoV-2 Infection
    View official trial listing →
  • Completed NCT NCT05164016

    Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients

    St. Jude Children's Research Hospital 21 participants Est. completion 2026-04-09 3 sites
    Other conditions: Cancer, Hematopoietic System--Cancer, Transplant-Related Cancer, Solid Tumor Malignancy, Hematologic Malignancy, Solid Organ Transplant, Hematopoietic Cell Transplant, Cellular Therapy
    View official trial listing →
  • Status unknown NCT NCT05164731

    Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above

    Not yet reported Chinese Academy of Medical Sciences 880 participants Est. completion 2022-10-30 1 site
    Other conditions: SARS-CoV2 Infection
    View official trial listing →
  • Suspended NCT NCT05165732

    Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19

    Not yet reported Sinovac Research and Development Co., Ltd. 480 participants Est. completion 2023-08-20 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05165966

    Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19

    Not yet reported Sinovac Life Sciences Co., Ltd. 340 participants Est. completion 2022-07-01 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05168709

    Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction

    Not yet reported Murdoch Childrens Research Institute 51 participants Est. completion 2022-09-29 1 site Stand-alone
    Other conditions: COVID-19, Vaccine Reaction, Immunization; Infection
    View official trial listing →
  • Completed NCT NCT05168800

    CONFIDENT: Supporting Long-term Care Workers During COVID-19

    Not yet reported Dartmouth-Hitchcock Medical Center 2634 participants Est. completion 2023-09-20 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Terminated NCT NCT05169008

    A Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and Adolescents

    Not yet reported CanSino Biologics Inc. 91 participants Est. completion 2023-01-13 2 sites Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Active, not recruiting NCT NCT05172011

    Understanding the Long-term Impact of COVID on Children and Families

    NYU Langone Health 15028 participants Est. completion 2029-09-30 65 sites
    Other conditions: SARS-CoV-2 Infection
    View official trial listing →
  • Completed NCT NCT05175742

    PTX-COVID19-B, an mRNA Humoral Vaccine, Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Demonstrate the Safety, Tolerability, and Immunogenicity of PTX-COVID19-B in Comparison to the Pfizer-BioNTech COVID-19 Vaccine.

    Not yet reported Providence Therapeutics Holdings Inc. 565 participants Est. completion 2023-03-29 11 sites
    Other conditions: Covid19 Vaccine
    View official trial listing →
  • Completed NCT NCT05178264

    Transverse Myelitis Related to SARS-CoV-2 Vaccines

    University Hospital, Caen 580 participants Est. completion 2021-12-10 1 site
    Other conditions: Vaccine Adverse Reaction
    View official trial listing →
  • Status unknown NCT NCT05185817

    Effectiveness of COVID-19 Vaccine in Hematopoietic Stem Cell Transplant Patients

    Not yet reported Tehran University of Medical Sciences 100 participants Est. completion 2023-07-01 1 site
    Other conditions: Hematopoietic Stem Cell Transplantation (HSCT), COVID-19 Vaccines, Immune System Tolerance
    View official trial listing →
  • Status unknown NCT NCT05191368

    Safety and Immunogenicity of Sars-cov-2 Vaccine in Patients With Rheumatic Diseases

    Yunnan University of Chinese Medicine 500 participants Est. completion 2022-06-01 1 site
    Other conditions: Rheumatic Disease
    View official trial listing →
  • Withdrawn NCT NCT05193279

    Safety and Immunogenicity of SCB-2019 in Children <18 Years of Age

    Not yet reported, Not yet reported Clover Biopharmaceuticals AUS Pty Est. completion 2022-12-15 2 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05197153

    A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19

    Not yet reported Medigen Vaccine Biologics Corp. 804 participants Est. completion 2022-10-28 4 sites
    Other conditions: COVID-19 Vaccine
    View official trial listing →
  • Completed NCT NCT05198336

    Immunogenicity of an Inactivated COVID-19 Vaccine

    Not yet reported Sinovac Research and Development Co., Ltd. 395 participants Est. completion 2022-12-30 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05204589

    Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-CoV-2 Vaccine

    Not yet reported Jiangsu Province Centers for Disease Control and Prevention 10285 participants Est. completion 2022-10-27 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05205746

    Phase II Study of AVX/COVID-12 Vaccine in Subjects With Prior SARS-CoV-2 Immunity Evidence

    Not yet reported Laboratorio Avi-Mex, S.A. de C.V. 158 participants Est. completion 2023-07-24 4 sites
    Other conditions: SARS CoV 2 Infection
    View official trial listing →
  • Completed NCT NCT05209009

    A Clinical Trial of COVAC-2 in Adults

    Not yet reported University of Saskatchewan 150 participants Est. completion 2024-03-01 2 sites
    Other conditions: Severe Acute Respiratory Syndrome Coronavirus 2
    View official trial listing →
  • Completed NCT NCT05212974

    COVID-19 Vaccine Hesitancy Among Nurses

    National Taiwan University Hospital 4258 participants Est. completion 2022-05-19 1 site
    Other conditions: COVID-19, Vaccine Hesitancy, Vaccination, Nurses
    View official trial listing →
  • Status unknown NCT NCT05213000

    Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress

    Not yet reported Iowa State University 80 participants Est. completion 2026-09-30 1 site Stand-alone
    Other conditions: Immunization
    View official trial listing →
  • Terminated NCT NCT05216510

    Assessment of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 Peptide Antigens

    Not yet reported Tonix Pharmaceuticals, Inc. 9 participants Est. completion 2022-09-17 1 site
    Other conditions: Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2
    View official trial listing →
  • Terminated NCT NCT05220397

    Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

    Not yet reported Mark Stegall 468 participants Est. completion 2025-02-28 3 sites
    Other conditions: Kidney Transplant Recipient
    View official trial listing →
  • Status unknown NCT NCT05225285

    Efficacy, Immunogenicity and Safety of Inactivated Vaccine (Coronavac) Against SARS-COV2 in Children and Adolescents

    Not yet reported Federal University of Espirito Santo 1120 participants Est. completion 2023-03-21 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05226702

    Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults.

    Not yet reported University of Saskatchewan 60 participants Est. completion 2023-11-13 3 sites
    Other conditions: Double Vaccinated for COVID-19 (For Phase 1 of the Study), Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)
    View official trial listing →
  • Active, not recruiting NCT NCT05228275

    Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer

    Children's Oncology Group 549 participants Est. completion 2028-03-31 72 sites
    Other conditions: COVID-19 Infection, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
    View official trial listing →
  • Completed NCT NCT05228912

    Immunization of 7 Different Vaccines Against SARS-COV-2 Across 4 Countries.

    Hospital Clinica Nova 1870 participants Est. completion 2022-10-30 1 site
    Other conditions: Vaccine Adverse Reaction, COVID-19, Vaccine Reaction
    View official trial listing →
  • Status unknown NCT NCT05230953

    Fourth COVID-19 Vaccine Dose- mRNA1273

    Not yet reported Sheba Medical Center 1000 participants Est. completion 2024-07-04 1 site
    Other conditions: COVID-19 Pandemic
    View official trial listing →
  • Completed NCT NCT05231590

    Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years

    Not yet reported Cinnagen 581 participants Est. completion 2022-09-30 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05233592

    Glycemic Effects of the COVID-19 Booster Vaccine in Type 1 Diabetes

    Johns Hopkins University 21 participants Est. completion 2023-04-04 1 site
    Other conditions: Type 1 Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT05234333

    COVID-19 Vaccines Associated Malaise

    University Hospital, Caen 1534706 participants Est. completion 2022-01-26 1 site
    Other conditions: Vaccine Adverse Reaction
    View official trial listing →
  • Completed NCT NCT05236270

    CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19)

    Not yet reported University of Oklahoma 312 participants Est. completion 2023-08-26 1 site Stand-alone
    Other conditions: COVID-19, Vaccine Refusal
    View official trial listing →
  • Status unknown NCT NCT05238454

    A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine

    Not yet reported Sinocelltech Ltd. 600 participants Est. completion 2022-12-01
    Other conditions: COVID-19, SARS-CoV-2 Infection
    View official trial listing →
  • Status unknown NCT NCT05239832

    Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity

    Not yet reported Livzon Pharmaceutical Group Inc. 34 participants Est. completion 2022-08-05 1 site Stand-alone
    Other conditions: COVID-19 Pandemic
    View official trial listing →
  • Completed NCT NCT05244356

    Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation

    Not yet reported Clinical Research Centre, Malaysia 5784 participants Est. completion 2021-06-07 1 site Stand-alone
    Other conditions: COVID-19, Respiratory Disease, Vaccine Refusal, Infectious Disease, Coronavirus Infections, Behavior, Health, Pneumonia, Respiratory Tract Infections, Lung Diseases, Pneumonia, Viral
    View official trial listing →
  • Completed NCT NCT05252442

    Association of the Risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 Vaccines

    AstraZeneca 7641136 participants Est. completion 2023-07-11 1 site
    Other conditions: Covid-19
    View official trial listing →
  • Terminated NCT NCT05252910

    Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents

    Pharm-Olam, LLC 33 participants Est. completion 2022-03-04 32 sites
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05258669

    Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults

    Not yet reported, Not yet reported Ocugen 400 participants Est. completion 2023-10-31 10 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05265065

    Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.

    Not yet reported Murdoch Childrens Research Institute 601 participants Est. completion 2024-11-06 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05268185

    The BOOSTED (Booster Options Or Switching Tested for Effectiveness and Downsides Study) Trial (COVID-19)

    Not yet reported University of California, San Francisco 301 participants Est. completion 2023-01-18 1 site
    Other conditions: COVID-19, Vaccine Reaction, COVID-19 Pandemic
    View official trial listing →
  • Completed NCT NCT05268679

    Covid-19 Vaccine Response in Heart Transplant Recipients

    Assistance Publique - Hôpitaux de Paris 190 participants Est. completion 2022-11-30 1 site
    Other conditions: Heart Transplantation, COVID-19 Virus Infection, COVID-19 Vaccine
    View official trial listing →
  • Status unknown NCT NCT05279365

    PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS

    Not yet reported, Not yet reported DHR Health Institute for Research and Development 1000 participants Est. completion 2023-08-31 4 sites
    Other conditions: SARS CoV 2 Infection, COVID-19
    View official trial listing →
  • Terminated NCT NCT05280158

    High-Dose Moderna mRNA-1273 Booster Study for Lung Transplant Recipients

    Not yet reported, Not yet reported University of California, Los Angeles 19 participants Est. completion 2023-02-27 1 site Stand-alone
    Other conditions: Lung Transplant Recipient, SARS-CoV-2, Immunosuppression
    View official trial listing →
  • Completed NCT NCT05285384

    Immunogenicity and Safety of a Booster Dose of the SpikoGen Vaccine in Kidney Transplant Recipients After Two Doses of Sinopharm Vaccine

    Not yet reported Cinnagen 43 participants Est. completion 2022-03-30 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05293665

    Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine

    Not yet reported Vaxxinity, Inc. 944 participants Est. completion 2023-09 7 sites
    Other conditions: COVID-19 Vaccines
    View official trial listing →
  • Withdrawn NCT NCT05298644

    COVID-19 Paediatric VLA2001-321 Study

    Not yet reported, Not yet reported Valneva Austria GmbH Est. completion 2025-08-30
    Other conditions: SARS-CoV-2 Infection
    View official trial listing →
  • Completed NCT NCT05303584

    Heterologous Boost Immunization with Ad5-nCoV After Three-dose Priming with an Inactivated SARS-CoV-2 Vaccine

    Not yet reported Jiangsu Province Centers for Disease Control and Prevention 362 participants Est. completion 2023-05-31 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05305573

    Assessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19.

    Not yet reported Hipra Scientific, S.L.U 26 participants Est. completion 2023-11-14 7 sites Stand-alone
    Other conditions: SARS-CoV-2 Infection
    View official trial listing →
  • Completed NCT NCT05310084

    Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

    Not yet reported BioNTech SE 1134 participants Est. completion 2022-10-05 26 sites
    Other conditions: SARS-CoV-2 Infection, COVID-19
    View official trial listing →
  • Completed NCT NCT05313035

    Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine

    Not yet reported, Not yet reported PT Bio Farma 360 participants Est. completion 2023-02-28 3 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05313074

    SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer Patients

    Not yet reported National Cancer Institute, Thailand 311 participants Est. completion 2022-02-25 1 site
    Other conditions: COVID-19, Cancer
    View official trial listing →
  • Completed NCT NCT05313087

    COVID-19 Vaccine Response in Chronic Respiratory Conditions

    National Jewish Health 360 participants Est. completion 2023-12-30 1 site
    Other conditions: SARS-CoV Infection
    View official trial listing →
  • Completed NCT NCT05313646

    Clinical Evaluation for Batch Consistency of Ad5-nCoV in Chinese Healthy Adults

    Not yet reported Jiangsu Province Centers for Disease Control and Prevention 1050 participants Est. completion 2021-09-08 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05315856

    Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms

    Korea University Guro Hospital 120 participants Est. completion 2022-12-31 3 sites
    Other conditions: COVID-19 Vaccination, Inflammation, Vaccine Immune Response, Vaccine Adverse Reaction
    View official trial listing →
  • Active, not recruiting NCT NCT05321407

    COVID-19 Vaccine Responses in PIDD Subjects

    Duke University 100 participants Est. completion 2026-07-31 3 sites
    Other conditions: X-linked Agammaglobulinemia, XLA, Primary Immune Deficiency, CVID, Common Variable Immunodeficiency, Primary Antibody Deficiencies, Secondary Hypogammaglobulinemia
    View official trial listing →
  • Status unknown NCT NCT05323461

    A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines

    Not yet reported Sinocelltech Ltd. 1800 participants Est. completion 2023-05-01 1 site
    Other conditions: COVID-19, SARS-CoV-2 Infection
    View official trial listing →
  • Status unknown NCT NCT05324319

    Homologous vs Heterologous Third Vaccination in Kidney Transplant Recipients Kidney Transplant Recipients

    Not yet reported Medical University of Vienna 200 participants Est. completion 2022-12-31 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05329038

    Immunogenicity,Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 Vaccine

    Not yet reported Sinovac Life Sciences Co., Ltd. 180 participants Est. completion 2024-02-20 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05329051

    A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years

    Not yet reported Sinocelltech Ltd. 400 participants Est. completion 2023-03-01
    Other conditions: SARS-CoV-2 Infection, COVID-19
    View official trial listing →
  • Status unknown NCT NCT05329064

    Determining Reactogenicity and Immunogenicity of Delayed COVID-19 Vaccine Schedule in Children

    Not yet reported KK Women's and Children's Hospital 150 participants Est. completion 2023-12-31 1 site
    Other conditions: Vaccine Reaction, COVID-19, Children, Only
    View official trial listing →
  • Completed NCT NCT05329220

    ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2

    Not yet reported Bavarian Nordic 4205 participants Est. completion 2023-10-05 57 sites
    Other conditions: COVID-19 Disease
    View official trial listing →
  • Status unknown NCT NCT05338177

    Pilot Trial on Immunosuppression Modulation to Increase SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients

    Not yet reported Medical University of Vienna 40 participants Est. completion 2022-11-14 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05352867

    Clinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese People

    Not yet reported AIM Vaccine Co., Ltd. 420 participants Est. completion 2023-06-21 2 sites
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Completed NCT NCT05354024

    Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine

    Not yet reported, Not yet reported Butantan Institute 4400 participants Est. completion 2024-09-25 6 sites
    Other conditions: Coronavirus Infections, Healthy
    View official trial listing →
  • Completed NCT NCT05364242

    VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection

    Not yet reported, Not yet reported Valneva Austria GmbH 178 participants Est. completion 2023-05-22 4 sites
    Other conditions: SARS-CoV-2 Infection
    View official trial listing →
  • Completed NCT NCT05366322

    A Study to Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among Immunocompromised Adults

    ModernaTX, Inc. 124879 participants Est. completion 2022-03-21 1 site
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Terminated NCT NCT05370040

    THEMBA II T-Cell Vaccine: Vaccination With saRNA COVID-19 Vaccines

    Not yet reported, Not yet reported ImmunityBio, Inc. 60 participants Est. completion 2024-03-11 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05373030

    Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 Vaccine

    Not yet reported Zhejiang Provincial Center for Disease Control and Prevention 200 participants Est. completion 2023-06-30 1 site Stand-alone
    Other conditions: Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization
    View official trial listing →
  • Completed NCT NCT05373472

    Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

    Not yet reported CanSino Biologics Inc. 150 participants Est. completion 2022-09-21 3 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05373485

    Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

    Not yet reported CanSino Biologics Inc. 43 participants Est. completion 2022-08-08 3 sites
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05374954

    Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and Above

    Not yet reported China National Biotec Group Company Limited 4200 participants Est. completion 2023-11-10 10 sites Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05375838

    A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old

    Not yet reported, Not yet reported ModernaTX, Inc. 550 participants Est. completion 2022-12-29 14 sites
    Other conditions: SARS-CoV-2, Influenza
    View official trial listing →
  • Completed NCT NCT05383560

    Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults

    Not yet reported Sheba Medical Center 179 participants Est. completion 2024-01-31 1 site
    Other conditions: COVID-19 Pandemic, Immunogenicity, SARS CoV 2 Infection, COVID-19
    View official trial listing →
  • Completed NCT NCT05386355

    Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool

    Not yet reported IDeA States Pediatric Clinical Trials Network 1934 participants Est. completion 2023-09-25 15 sites Stand-alone
    Other conditions: COVID-19 Vaccines, Telemedicine, Vaccine Hesitancy, Pediatric ALL
    View official trial listing →
  • Status unknown NCT NCT05387252

    Glucoside- and Rutinoside-rich Crude Material for Relieving Side Effects of COVID-19 Vaccines

    Not yet reported Taipei Medical University 93 participants Est. completion 2023-05-31
    Other conditions: Vaccine Adverse Reaction, Side-Effect
    View official trial listing →
  • Withdrawn NCT NCT05387317

    Evaluation of COVID-19 Vaccines Given as a Booster in Healthy Adults in Indonesia (MIACoV Indonesia)

    Not yet reported Murdoch Childrens Research Institute Est. completion 2025-10 3 sites Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Active, not recruiting NCT NCT05389319

    A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults

    Not yet reported University Hospital Tuebingen 96 participants Est. completion 2026-12-31 2 sites
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05394012

    A Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19

    Not yet reported Walvax Biotechnology Co., Ltd. 120 participants Est. completion 2023-06
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05396573

    A Phase 1b Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19

    Not yet reported Walvax Biotechnology Co., Ltd. 120 participants Est. completion 2023-07
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05397223

    A Study of Modified mRNA Vaccines in Healthy Adults

    Not yet reported ModernaTX, Inc. 308 participants Est. completion 2026-02-27 8 sites
    Other conditions: SARS-CoV-2, Seasonal Influenza, Respiratory Syncytial Virus, Cytomegalovirus
    View official trial listing →
  • Completed NCT NCT05403307

    A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil

    Hospital Moinhos de Vento 757 participants Est. completion 2023-07-17 5 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05406908

    Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases

    Not yet reported Mahidol University 109 participants Est. completion 2023-05-01 1 site Stand-alone
    Other conditions: Bullous Dermatoses, Psoriasis, COVID-19 Vaccines
    View official trial listing →
  • Status unknown NCT NCT05409300

    Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea

    Not yet reported ANRS, Emerging Infectious Diseases 200 participants Est. completion 2025-02 2 sites
    Other conditions: COVID-19, Vaccine Adverse Reaction, Sars-CoV-2 Infection, Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT05424952

    The Effectiveness of Conversational AI Service (Chatbot) Utilization on Vaccine Confidence

    Not yet reported The University of Hong Kong 1000 participants Est. completion 2023-02-17 3 sites
    Other conditions: Vaccination Hesitancy
    View official trial listing →
  • Completed NCT NCT05433285

    Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine

    Not yet reported PT Bio Farma 4050 participants Est. completion 2023-08-31 4 sites
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05434585

    A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines

    Not yet reported Suzhou Abogen Biosciences Co., Ltd. 60 participants Est. completion 2023-08-30 2 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05435027

    Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV)

    Not yet reported Gritstone bio, Inc. 342 participants Est. completion 2024-03-06 4 sites
    Other conditions: COVID-19, SARS-CoV-2
    View official trial listing →
  • Status unknown NCT NCT05439824

    A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More

    Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 450 participants Est. completion 2023-06-28 2 sites
    Other conditions: SARS-CoV-2 Infection
    View official trial listing →
  • Withdrawn NCT NCT05442684

    A Study to Evaluate the Safety and Immunogenicity of Ad5-vector Based Vaccine Against Coronavirus Variants in Adults (≥18 Years) Immunized With 2 Doses of mRNA Vaccines Plus One Dose of Booster AZD1222 Vaccine

    Not yet reported CanSino Biologics Inc. Est. completion 2023-06-30 Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05453487

    Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine

    Not yet reported China National Biotec Group Company Limited 360 participants Est. completion 2023-06-30 2 sites Stand-alone
    Other conditions: COVID-19, Rabies
    View official trial listing →
  • Status unknown NCT NCT05455983

    COVID-19 Vaccine and Development of Immune Thrombocytopenic Purpura

    Assiut University 500 participants Est. completion 2023-12-01 1 site
    Other conditions: COVID-19 Vaccine
    View official trial listing →
  • Completed NCT NCT05463354

    Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

    Not yet reported WestVac Biopharma Co., Ltd. 410 participants Est. completion 2024-01-26 1 site Stand-alone
    Other conditions: COVID-19, SARS-CoV-2 Infection
    View official trial listing →
  • Status unknown NCT NCT05468021

    Puerto Rico COVID-19 Vaccine Uptake Study

    Not yet reported University of Puerto Rico 394 participants Est. completion 2023-06 2 sites Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05470894

    Liver Injury After COVID-19 Vaccination

    Humanity & Health Medical Group Limited 379 participants Est. completion 2024-12-31 3 sites
    Other conditions: Subjects After COVID-19 Vaccination
    View official trial listing →
  • Status unknown NCT NCT05471635

    Variables Influencing Anti-COVID-19 Vaccinations Around the World: an Analysis Conducted on Aggregated Data Sourced From Institutional Databases to Understand Whether and How Different Variables Could Affect the Vaccine Coverage (WORLDCOV: Worldwide Determinants of COVID-19 Vaccination)

    Alberto Peano 205 participants Est. completion 2022-07-20 1 site
    Other conditions: COVID-19 Vaccines
    View official trial listing →
  • Status unknown NCT NCT05473936

    A CHW Intervention to Identify and Decrease Barriers to COVID 19 Testing & Vaccination

    Not yet reported Charles Drew University of Medicine and Science 66 participants Est. completion 2023-05 2 sites
    Other conditions: Vaccine Hesitancy, COVID-19 Testing, Community Health Workers
    View official trial listing →
  • Completed NCT NCT05475704

    Effectiveness of Chinese COVID-19 Vaccines in Latin America and the Caribbean

    P95 59 participants Est. completion 2023-07-11 5 sites
    Other conditions: COVID-19
    View official trial listing →
  • Withdrawn NCT NCT05476822

    Profiling Spike Protein Antibody Response Post COVID-19 Booster

    David Grant U.S. Air Force Medical Center Est. completion 2023-06
    Other conditions: COVID-19 Booster, Spike Protein IgG Antibody
    View official trial listing →
  • Completed NCT NCT05477186

    Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old

    Not yet reported GlaxoSmithKline 185 participants Est. completion 2023-08-18 17 sites
    Other conditions: COVID-19, SARS-CoV-2
    View official trial listing →
  • Completed NCT NCT05481801

    Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-2)

    Castilla-La Mancha Health Service 300 participants Est. completion 2022-12-31 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT05490108

    Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.

    Not yet reported, Not yet reported Shanghai Zerun Biotechnology Co.,Ltd 60 participants Est. completion 2023-08 1 site
    Other conditions: SARS-CoV-2 Infection, COVID-19
    View official trial listing →
  • Status unknown NCT NCT05492643

    The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine

    Not yet reported Zhongnan Hospital 1000 participants Est. completion 2023-03-01 1 site
    Other conditions: SARS-CoV-2, Safety, Immunotoxicity
    View official trial listing →
  • Status unknown NCT NCT05493917

    A Real-world Study to Evaluate the Safety and Immunogenicity of a Third-dose Booster After Two Doses of an Inactivated COVID-19 Vaccine

    Huashan Hospital 2000 participants Est. completion 2022-12-31 1 site
    Other conditions: COVID-19, Vaccine Reaction
    View official trial listing →
  • Completed NCT NCT05499299

    Volatility and Heterogeneity of Vaccine Sentiments Means Continuous Monitoring is Needed When Measuring Message Effectiveness

    Not yet reported The University of Hong Kong 127000 participants Est. completion 2022-04-01 1 site
    Other conditions: Vaccine-Preventable Diseases, Vaccine Refusal
    View official trial listing →
  • Completed NCT NCT05499351

    A Study of Booster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza Vaccine and Pneumococcal Polysaccharide Vaccine

    Not yet reported Sinovac Biotech Co., Ltd 3000 participants Est. completion 2022-05-05 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Active, not recruiting NCT NCT05507671

    The Role of BCG Vaccine in the Clinical Evolution of COVID-19 and in the Efficacy of Anti-SARS-CoV-2 Vaccines

    Not yet reported Oswaldo Cruz Foundation 556 participants Est. completion 2025-12-31 4 sites
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05508477

    UNAIR Inactivated COVID-19 Vaccine Phase III (Immunobridging Study)

    Not yet reported Dr. Soetomo General Hospital 4005 participants Est. completion 2023-05-28 5 sites
    Other conditions: COVID-19 Pandemic, COVID-19 Vaccines
    View official trial listing →
  • Status unknown NCT NCT05518760

    COVID-19 Effectiveness Study in the Philippines

    University of the Philippines 3000 participants Est. completion 2024-03-15 1 site
    Other conditions: COVID-19, Vaccine Effectiveness Against COVID-19, Hospitalized COVID-19
    View official trial listing →
  • Completed NCT NCT05525208

    Booster Study of COVID-19 Protein Subunit Recombinant Vaccine

    Not yet reported PT Bio Farma 696 participants Est. completion 2023-08-04 2 sites Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05531058

    The Impact of a Web-based Psychoeducation Programme with a Motivational AI Chatbot on Covid-19 Vaccine Hesitancy

    Not yet reported The Hong Kong Polytechnic University 168 participants Est. completion 2024-06-01 1 site
    Other conditions: Vaccine Hesitancy, COVID-19
    View official trial listing →
  • Status unknown NCT NCT05534035

    Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older

    Not yet reported Everest Medicines (Singapore) Pte. Ltd. 450 participants Est. completion 2023-10-18
    Other conditions: SARS-CoV-2 Infection
    View official trial listing →
  • Withdrawn NCT NCT05541393

    Engaging Church Health Ministries to Decrease Coronavirus Disease-19 Vaccine Hesitancy in Underserved Populations

    Not yet reported Pennington Biomedical Research Center Est. completion 2023-06-30 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05541861

    Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People

    Not yet reported BioNTech SE 383 participants Est. completion 2024-11-22 17 sites
    Other conditions: SARS-CoV-2 Infection, COVID-19
    View official trial listing →
  • Completed NCT NCT05542862

    Booster Study of SpikoGen COVID-19 Vaccine

    Not yet reported Vaxine Pty Ltd 81 participants Est. completion 2025-09-16 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Terminated NCT NCT05543642

    The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)

    Not yet reported Oregon Health and Science University 129 participants Est. completion 2026-08-14 7 sites
    Other conditions: Rheumatic Diseases
    View official trial listing →
  • Completed NCT NCT05543993

    COVID Booster in Pregnancy and Lactation

    Thomas Jefferson University 150 participants Est. completion 2024-06-10 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05548439

    Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a

    Not yet reported VBI Vaccines Inc. 103 participants Est. completion 2024-01-16 7 sites
    Other conditions: COVID-19, Coronavirus Infections
    View official trial listing →
  • Completed NCT NCT05567471

    Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose

    Not yet reported Bharat Biotech International Limited 875 participants Est. completion 2022-09-28 9 sites
    Other conditions: COVID-19 Respiratory Infection
    View official trial listing →
  • Status unknown NCT NCT05568693

    Sequential Enhanced Safety Study of a Novel Coronavirus Messenger RNA (mRNA) Vaccine in Adults Aged 18 Years and Older.

    Not yet reported Yu Qin 800 participants Est. completion 2023-03-21 1 site
    Other conditions: Corona Virus Disease 2019(COVID-19)
    View official trial listing →
  • Completed NCT NCT05572879

    A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

    Not yet reported EuBiologics Co.,Ltd 2600 participants Est. completion 2024-02-09 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05584735

    Determining the Relationship Between Gut Microbiota and Immune Response to Influenza or COVID-19 Vaccine

    University of Wisconsin, Madison 46 participants Est. completion 2025-03-20 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Status unknown NCT NCT05585567

    A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5

    Not yet reported Livzon Pharmaceutical Group Inc. 48 participants Est. completion 2023-09-11 1 site
    Other conditions: COVID-19 Pandemic
    View official trial listing →
  • Withdrawn NCT NCT05587881

    Clinical Study on the Impact of Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell Transplantation

    The First Affiliated Hospital of Soochow University Est. completion 2023-11-01 1 site
    Other conditions: Hematologic Diseases
    View official trial listing →
  • Completed NCT NCT05599555

    Community-based Sero-epidemiological Study of COVID-19

    The University of Hong Kong 9600 participants Est. completion 2023-03-31 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05602558

    The Phase Ⅱ/Ⅲ Trial of LYB001

    Not yet reported, Not yet reported Yantai Patronus Biotech Co., Ltd. 18000 participants Est. completion 2024-02
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05603052

    A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older

    Not yet reported EuBiologics Co.,Ltd 2852 participants Est. completion 2024-01-15 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05604690

    Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers

    Not yet reported Intravacc B.V. 40 participants Est. completion 2024-01-15 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Enrolling by invitation NCT NCT05610423

    Covid-19 Vaccine Associated Myocarditis and Pericarditis in Norway

    Oslo University Hospital 100 participants Est. completion 2032-12-31 1 site
    Other conditions: Myocarditis
    View official trial listing →
  • Withdrawn NCT NCT05614245

    Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant

    Not yet reported VBI Vaccines Inc. Est. completion 2024-06 4 sites
    Other conditions: COVID-19, Coronavirus Infections
    View official trial listing →
  • Status unknown NCT NCT05618548

    Vaccination Against COVID-19 in Pregnant and Lactating Women in Belgium

    Universiteit Antwerpen 110 participants Est. completion 2023-06-30 1 site
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT05630313

    Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil

    The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 100 participants Est. completion 2023-09-30 1 site
    Other conditions: Vaccine-induced Thrombotic Thrombocytopenia Syndrome, Guillain-Barre Syndrome, Acute Disseminated Encephalomyelitis, Transverse Myelitis
    View official trial listing →
  • Not yet recruiting NCT NCT05633446

    Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)

    Not yet reported, Not yet reported Gylden Pharma Ltd 110 participants Est. completion 2026-12-01 2 sites
    Other conditions: Coronavirus, SARS-CoV-2 Infection, COVID-19
    View official trial listing →
  • Completed NCT NCT05652543

    A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine

    Not yet reported Sinocelltech Ltd. 518 participants Est. completion 2024-01-15 4 sites Stand-alone
    Other conditions: COVID-19 Pandemic
    View official trial listing →
  • Completed NCT NCT05655351

    Effect of a Vaccination Against COVID-19 on Monocyte Production of Oxygenated Derivatives.

    Not yet reported Centre Hospitalier Universitaire de Nīmes 30 participants Est. completion 2024-07-30 1 site
    Other conditions: CORONAVIRUS INFECTIONS
    View official trial listing →
  • Status unknown NCT NCT05679466

    An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older

    Not yet reported Yu Qin 3300 participants Est. completion 2023-12-31 1 site
    Other conditions: Prevention of COVID-19 Caused by SARS-CoV-2
    View official trial listing →
  • Status unknown NCT NCT05682638

    A Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19

    Not yet reported AIM Vaccine Co., Ltd. 34000 participants Est. completion 2025-12 1 site
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Completed NCT NCT05697705

    Effectiveness of the Oxford-AstraZeneca COVID-19 Vaccine as a 2nd Booster, the REFORCO-Brazil Study

    AstraZeneca 188814085 participants Est. completion 2023-05-18 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05715944

    Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2

    Not yet reported Botswana Harvard AIDS Institute Partnership 10888 participants Est. completion 2022-12-30 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05745545

    Clinical Trial of COVID-19 Vaccine(SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine) in Participants Aged 18 Years and Over

    Not yet reported AIM Vaccine Co., Ltd. 3200 participants Est. completion 2023-11 1 site
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Status unknown NCT NCT05749926

    Immunogenicity and Reactogenicity of the Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine

    Not yet reported Assistance Publique - Hôpitaux de Paris 248 participants Est. completion 2024-07-12 1 site Stand-alone
    Other conditions: Vaccine Reaction, COVID-19
    View official trial listing →
  • Completed NCT NCT05765578

    An Observational Study of Moderna COVID-19 Bivalent Vaccines (Original and Omicron BA.4/BA.5) and 2023 Updated mRNA COVID-19 Vaccines (XBB.1.5)

    ModernaTX, Inc. 1713 participants Est. completion 2024-06-17 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05770180

    Phase II Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell)

    Not yet reported WestVac Biopharma Co., Ltd. 450 participants Est. completion 2024-04-09 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Terminated NCT NCT05788185

    Safety & Immunogenicity of RVM-V001/RVM-V002 or RVMV001+RVMV002 (Co Administered as Separate Injections) in Healthy Individuals

    Not yet reported, Not yet reported RVAC Medicines (US), Inc. 24 participants Est. completion 2023-09-21 1 site
    Other conditions: Infectious Disease, COVID-19
    View official trial listing →
  • Completed NCT NCT05808348

    Effects of COVID-19 on the Elderly

    Kırklareli University 114 participants Est. completion 2023-05-11 1 site
    Other conditions: Pain, Fear, Falling, Physical Activity, COVID-19, Aged
    View official trial listing →
  • Status unknown NCT NCT05812586

    Assessment of Immunogenicity, Safety and Reactogenicity of a Booster Dose of Various COVID-19 Vaccine Platforms in Individuals Primed With Several Regimes.

    Not yet reported D'Or Institute for Research and Education 760 participants Est. completion 2023-09 2 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05815498

    A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19

    Not yet reported ModernaTX, Inc. 13553 participants Est. completion 2025-04-12 230 sites
    Other conditions: COVID-19
    View official trial listing →
  • Active, not recruiting NCT NCT05822219

    Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases

    Not yet reported Northwestern University 60 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Rheumatic Diseases, COVID-19 Vaccine, COVID-19, SLE
    View official trial listing →
  • Status unknown NCT NCT05831826

    Effectiveness and Safety of the Inactivated COVID-19 Vaccine in Thousands of Patients With Autoimmune Diseases in China

    Zhejiang Chinese Medical University 1200 participants Est. completion 2024-12 1 site
    Other conditions: COVID-19 Vaccines, Autoimmune Diseases
    View official trial listing →
  • Status unknown NCT NCT05855408

    Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults

    Not yet reported Jiangsu Province Centers for Disease Control and Prevention 10000 participants Est. completion 2024-12-31 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05863429

    Observational National Vaccine Study

    Health Institutes of Turkey 200 participants Est. completion 2024-04-01 8 sites
    Other conditions: COVID-19 Infection
    View official trial listing →
  • Completed NCT NCT05866237

    COVID-19 Vaccine Uptake Amongst Underserved Populations in East London

    Not yet reported Queen Mary University of London 5903 participants Est. completion 2025-04-30 5 sites
    Other conditions: COVID-19, Influenza, Vaccination Refusal
    View official trial listing →
  • Status unknown NCT NCT05873374

    Evaluation of Safety, Tolerability, Reactogenicity, Immunogenicity of Baiya SARS-CoV-2 Vax 2 as a Booster for COVID-19

    Not yet reported Baiya Phytopharm Co., Ltd. 75 participants Est. completion 2024-08 1 site
    Other conditions: COVID-19 Vaccine, COVID-19
    View official trial listing →
  • Terminated NCT NCT05876377

    Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data

    Pfizer 1 participants Est. completion 2026-05-31 1 site
    Other conditions: SARS-CoV-2, COVID-19, Post-Acute COVID-19 Syndrome
    View official trial listing →
  • Completed NCT NCT05894525

    Post-Marketing Safety Study in Japan in Participants With High Risk of Severe Exacerbation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine

    ModernaTX, Inc. 8844 participants Est. completion 2023-05-26 1 site
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Completed NCT NCT05894590

    Post-Marketing Non-Acute Safety Study in Japan After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons at High Risk of Severe COVID-19

    ModernaTX, Inc. 13680 participants Est. completion 2023-12-20 1 site
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Completed NCT NCT05895110

    To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2

    Not yet reported Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 240 participants Est. completion 2022-11-19 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05907044

    A Study to Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults

    Not yet reported Affiliated Hospital of Yunnan University 376 participants Est. completion 2023-11-23 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05911048

    A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination

    Not yet reported WestVac Biopharma Co., Ltd. 3100 participants Est. completion 2025-12-30
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05911087

    A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2

    Not yet reported, Not yet reported Stemirna Therapeutics 800 participants Est. completion 2024-02-01 Stand-alone
    Other conditions: Immunogenicity, Safety
    View official trial listing →
  • Completed NCT NCT05919472

    Effects of Oral Iron Supplementation on Vaccine Response in Iron Deficient Kenyan Women

    Not yet reported Nicole Stoffel 180 participants Est. completion 2024-07-16 1 site Stand-alone
    Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT05924685

    PREPARE-iVAC Trial

    Not yet reported University Medical Center Groningen 110 participants Est. completion 2024-02-27 7 sites
    Other conditions: COVID-19 Vaccines, Varicella Zoster Vaccine, Vaccine Response, Immunosuppression
    View official trial listing →
  • Withdrawn NCT NCT05926440

    Immunogenicity and Safety Study of SCB-2023 Vaccine as a Booster in Adults

    Not yet reported Clover Biopharmaceuticals AUS Pty Est. completion 2023-08-17 3 sites
    Other conditions: COVID-19
    View official trial listing →
  • Terminated NCT NCT05926544

    COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists

    Not yet reported University of North Carolina, Chapel Hill 16 participants Est. completion 2024-06-20 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT05933304

    A Study of the Effectiveness of Moderna COVID-19 Vaccine

    ModernaTX, Inc. 927004 participants Est. completion 2023-11-17 1 site
    Other conditions: SARS-CoV-2, COVID-19
    View official trial listing →
  • Status unknown NCT NCT05933512

    A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines

    Not yet reported Sinocelltech Ltd. 600 participants Est. completion 2024-11-10
    Other conditions: COVID-19, SARS-CoV-2 Infection
    View official trial listing →
  • Completed NCT NCT05938075

    Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa

    Not yet reported Vaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company 130 participants Est. completion 2024-07-25 2 sites
    Other conditions: SARS-CoV, SARS-CoV-2
    View official trial listing →
  • Status unknown NCT NCT05939596

    A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)

    Not yet reported AIM Vaccine Co., Ltd. 60 participants Est. completion 2024-08-25 1 site
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Status unknown NCT NCT05939648

    A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)

    Not yet reported AIM Vaccine Co., Ltd. 450 participants Est. completion 2024-12-30 1 site
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Completed NCT NCT05970887

    Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines

    Not yet reported Catholic Kwandong University 154 participants Est. completion 2023-12-15 1 site
    Other conditions: Immune Response, Safety
    View official trial listing →
  • Completed NCT NCT05975060

    A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.

    Not yet reported, Not yet reported Novavax 660 participants Est. completion 2024-05-20 30 sites
    Other conditions: COVID-19
    View official trial listing →
  • Terminated NCT NCT05977127

    Intradermal Administration of a COVID-19 mRNA Vaccine in Elderly

    Not yet reported Radboud University Medical Center 48 participants Est. completion 2024-03-21 1 site
    Other conditions: Vaccination; Infection, COVID-19
    View official trial listing →
  • Completed NCT NCT06006858

    Post Authorization Safety Study Moderna COVID-19 Primary Vaccine

    PT Bio Farma 1284 participants Est. completion 2023-03-31 18 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT06020118

    Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations

    Not yet reported Duke University 455 participants Est. completion 2024-05-17 8 sites
    Other conditions: Influenza, COVID-19
    View official trial listing →
  • Terminated NCT NCT06022224

    A 2nd Generation E1/E2B/E3-Deleted Adenoviral COVID-19 Vaccine: The TCELL VACCINE TRIAL

    Not yet reported, Not yet reported ImmunityBio, Inc. 35 participants Est. completion 2023-07-19 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT06036134

    Reducing COVID-19 Vaccine Hesitancy Among Hispanic Parents

    Not yet reported Arizona State University 80 participants Est. completion 2025-08-31 1 site Stand-alone
    Other conditions: Vaccine-Preventable Diseases, COVID-19 Pandemic, Health-Related Behavior, Health Knowledge, Attitudes, Practice, Narration
    View official trial listing →
  • Completed NCT NCT06065176

    The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection

    Not yet reported Sarang K. Yoon, DO, MOH 1188 participants Est. completion 2024-09-09 1 site
    Other conditions: COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection, Upper Respiratory Tract Infection, Upper Respiratory Disease
    View official trial listing →
  • Status unknown NCT NCT06091410

    Immunogenicity of Concomitant Administration of COVID-19 Vaccines With Influenza Vaccines

    Not yet reported Catholic Kwandong University 62 participants Est. completion 2025-06-25 2 sites Stand-alone
    Other conditions: COVID-19, Influenza, Vaccine Reaction, Contaminant Injected
    View official trial listing →
  • Status unknown NCT NCT06113744

    A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

    Not yet reported CNBG-Virogin Biotech (Shanghai) Ltd. 164 participants Est. completion 2024-06 1 site
    Other conditions: SARS-CoV-2 Infection
    View official trial listing →
  • Completed NCT NCT06116669

    Effects of Oral Iron Supplementation Before vs at Time of Vaccination on Immune Response in Iron Deficient Kenyan Women

    Not yet reported Swiss Federal Institute of Technology 215 participants Est. completion 2024-07-31 1 site Stand-alone
    Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Terminated NCT NCT06156228

    Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos

    Not yet reported San Diego State University 238 participants Est. completion 2025-04-01 2 sites
    Other conditions: Vaccine Hesitancy
    View official trial listing →
  • Completed NCT NCT06189040

    Immunogenicity After COVID-19 Vaccines in Adapted Schedules

    Not yet reported Universiteit Antwerpen 580 participants Est. completion 2022-07-08 4 sites
    Other conditions: Coronavirus Disease 2019, COVID-19
    View official trial listing →
  • Active, not recruiting NCT NCT06189053

    A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)

    ModernaTX, Inc. 1500 participants Est. completion 2028-10-31 1 site
    Other conditions: Myocarditis
    View official trial listing →
  • Status unknown NCT NCT06259578

    UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study)

    Not yet reported Dr. Soetomo General Hospital 400 participants Est. completion 2024-12-29 1 site
    Other conditions: COVID-19 Pandemic, COVID-19 Vaccines, COVID-19 Virus Disease
    View official trial listing →
  • Status unknown NCT NCT06272253

    UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects

    Not yet reported Dr. Soetomo General Hospital 250 participants Est. completion 2024-07-19 1 site
    Other conditions: COVID-19 Pandemic, COVID-19 Vaccines
    View official trial listing →
  • Completed NCT NCT06279871

    Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults

    Not yet reported Arcturus Therapeutics, Inc. 1514 participants Est. completion 2024-11-21 29 sites Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT06300853

    Understanding Adaptive Immune Response After COVID-19 Vaccination Boosters to Improve Vaccination Strategies in Vulnerable Groups.

    Not yet reported IRCCS Sacro Cuore Don Calabria di Negrar 350 participants Est. completion 2025-11 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT06303635

    Safety of UFRJvac, Trivalent COVID-19 Vaccine

    Azidus Brasil 156 participants Est. completion 2025-11-25
    Other conditions: Healthy People
    View official trial listing →
  • Active, not recruiting NCT NCT06333704

    Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT, SPIKEVAX X Injection, SPIKEVAX JN Injection and SPIKEVAX IN PRE-FILLED SYRINGE

    ModernaTX, Inc. 4207 participants Est. completion 2029-03-29 26 sites
    Other conditions: SARS-CoV-2
    View official trial listing →
  • Completed NCT NCT06352580

    Covid-19 Pandemic and Pediatric Dentistry

    Abant Izzet Baysal University 438 participants Est. completion 2022-06-30 1 site
    Other conditions: COVID-19 Pandemic
    View official trial listing →
  • Completed NCT NCT06360744

    A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines.

    Not yet reported Jens D Lundgren, MD 25 participants Est. completion 2023-12-31 5 sites
    Other conditions: SARS CoV 2 Infection
    View official trial listing →
  • Completed NCT NCT06369272

    Study to Assess Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy

    ModernaTX, Inc. 1192 participants Est. completion 2023-10-20 1 site
    Other conditions: Maternal Outcomes, Infant Outcomes, Pregnancy
    View official trial listing →
  • Completed NCT NCT06381843

    A Clinical Study to Evaluate the Safety and Immunogenicity of the Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

    Not yet reported WestVac Biopharma Co., Ltd. 120 participants Est. completion 2023-12-30 1 site Stand-alone
    Other conditions: COVID-19, SARS-CoV-2 Infection
    View official trial listing →
  • Completed NCT NCT06409663

    A Strain Change Study for SARS-CoV-2 rS Vaccines

    Not yet reported Novavax 60 participants Est. completion 2025-04-17 2 sites Stand-alone
    Other conditions: Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    View official trial listing →
  • Completed NCT NCT06503900

    Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study

    Not yet reported Duke University 98 participants Est. completion 2025-11-19 6 sites Stand-alone
    Other conditions: Birth Outcomes, Safety, Adverse Event Following Immunization
    View official trial listing →
  • Withdrawn NCT NCT06567457

    Immunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in Adults

    Not yet reported Clover Biopharmaceuticals AUS Pty Est. completion 2024-10
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT06575114

    COVID-19 Vaccination Willingness in Older Adults Based on Self-determination Theory

    Not yet reported Jing-Shan Deng 264 participants Est. completion 2023-11-17 1 site
    Other conditions: Old Age; Debility, Vaccine Hesitancy, Vaccine Refusal
    View official trial listing →
  • Completed NCT NCT06603090

    Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season

    Not yet reported Columbia University 66147 participants Est. completion 2025-04-30 4 sites Stand-alone
    Other conditions: Influenza, COVID-19, Vaccination Hesitancy
    View official trial listing →
  • Active, not recruiting NCT NCT06605625

    Vaccine Responses in Cancer

    Abramson Cancer Center at Penn Medicine 250 participants Est. completion 2028-10 1 site
    Other conditions: Viral Vaccines
    View official trial listing →
  • Completed NCT NCT06680375

    A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

    Not yet reported GlaxoSmithKline 106 participants Est. completion 2025-06-09 9 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT06695130

    Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older

    Not yet reported, Not yet reported Sanofi 980 participants Est. completion 2026-04-03 12 sites
    Other conditions: COVID-19 Immunization, Influenza Immunization
    View official trial listing →
  • Completed NCT NCT06763887

    Evaluation of Immunogenicity of COVID-19 Vaccine in Chinese Population

    Xijing Hospital 100 participants Est. completion 2024-06-30 1 site
    Other conditions: COVID
    View official trial listing →
  • Completed NCT NCT06821061

    A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

    Not yet reported, Not yet reported BioNTech SE 2650 participants Est. completion 2025-12-17 31 sites Stand-alone
    Other conditions: Influenza, COVID-19 (Coronavirus Disease 2019)
    View official trial listing →
  • Completed NCT NCT06831786

    Immunogenicity of COVID-19 Vaccine Co-administration With Influenza Vaccine in Healthy Volunteers

    Not yet reported Prince of Songkla University 36 participants Est. completion 2024-05-31 1 site
    Other conditions: COVID - 19
    View official trial listing →
  • Active, not recruiting NCT NCT07051031

    COVID-19 Reactogenicity

    Not yet reported Marcel Curlin 1000 participants Est. completion 2026-06-14 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT07089706

    A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations

    Not yet reported ModernaTX, Inc. 832 participants Est. completion 2026-06-16 5 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT07095231

    Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 60 participants Est. completion 2026-06-16 3 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT07134725

    Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG

    Not yet reported, Not yet reported Federal University of Minas Gerais 432 participants Est. completion 2025-05-07 1 site
    Other conditions: COVID - 19
    View official trial listing →
  • Completed NCT NCT07254442

    Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing

    Zonguldak Bulent Ecevit University 90 participants Est. completion 2022-03-01 1 site
    Other conditions: Hearing, COVID - 19, Ototoxicity
    View official trial listing →
  • Completed NCT NCT07300839

    A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

    Not yet reported BioNTech SE 5240 participants Est. completion 2026-09-22 196 sites
    Other conditions: COVID-19, SARS-COV-2 Infection
    View official trial listing →
  • Not yet recruiting NCT NCT07390968

    Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Patients

    Not yet reported Fred Hutchinson Cancer Center 56 participants Est. completion 2029-01-01 1 site
    Other conditions: Hematopoietic and Lymphatic System Neoplasm
    View official trial listing →
  • Completed NCT NCT07610512

    Immunomodulatory Effect of Probiotics on the Immunogenicity of Anti-SARS-CoV-2 Vaccines

    Not yet reported Grape King Bio Ltd. 138 participants Est. completion 2022-03-31 1 site
    Other conditions: COVID-19, Immune Response
    View official trial listing →
  • Completed NCT NCT07655180

    Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine

    Not yet reported Invivyd, Inc. 210 participants Est. completion 2026-08-15 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Not yet recruiting NCT NCT07703475

    A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 80 participants Est. completion 2027-11-15 4 sites
    Other conditions: COVID -19
    View official trial listing →
  • Completed NCT NCT07758309

    Online Games to Help Canadian and U.S. Adults Identify COVID-19 and Vaccine Misinformation: Three Sequential Randomized Studies

    Not yet reported University of South Carolina 3637 participants Est. completion 2020-12-28 1 site
    Other conditions: COVID-19, Vaccine Hesitancy, Health Misinformation, Communication
    View official trial listing →
  • Active, not recruiting NCT NCT07798648

    A Study of COVID-19 Vaccine(s) in Children and Adults

    Not yet reported BioNTech SE 713 participants Est. completion 2027-04-12 15 sites
    Other conditions: COVID-19 Vaccines
    View official trial listing →
  • Not yet recruiting NCT NCT07871448

    Flu COVID Vaccine Views

    George Washington University 550 participants Est. completion 2028-04-01 2 sites
    Other conditions: Influenza, COVID-19, Vaccination Willingness
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.